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ABSTRACT
The limitations of large bone defect regeneration has brought the focus of Bone
Tissue Engineering research on fabricating three-dimensional bone-mimetic grafts that
could enhance osteogenesis and vascularization. Osteons composed of apatite-deposited
aligned collagen nanofiber layers are the fundamental building blocks of cortical bone. In
natural cortical bone, mineralization is mediated by extracellular matrix (ECM) proteins
with amino acid sequences rich in glutamic acid. This dissertation is focused on the
establishment of a novel biomimetic approach to engineer scaffolds for healing large
bone defects.
In the first part, we investigated the effect of calcium phosphate (CaP) deposition
on aligned surface-modified nanofibers (NF) with a glutamic acid peptide (GLU-NF) on
osteogenic differentiation of marrow stromal cells (MSCs). In order to mimic the
morphology of the bone ECM, the EEGGC peptide (GLU) with two glutamic acid
residues was conjugated to a low molecular weight polylactide (PLA) macromer. The
synthesized PLA-GLU polymer-peptide conjugate was blended with high molecular
weight poly(lactide-co-glycolide) (PLGA) and electrospun to form GLU-NF. GLU-NF
microsheets were incubated in a modified simulated body fluid (SBF) for nucleation and
growth of CaP crystals on the fiber surface. To achieve a high CaP to fiber ratio, a layerby-layer (LBL) approach was used to improve diffusion of calcium and phosphate ions
inside the microsheets. Results demonstrate that surface modification of aligned synthetic
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NF with EEGGC peptide significantly increased nucleation and growth of CaP crystals
on the fibers, leading to increased mechanical properties and osteogenic differentiation of
MSCs. In addition, CaP to fiber ratios as high as 200%, which lie between those of
cancellous (160%) and cortical (310%) bone, were obtained with the LBL approach.
In the second part, the perforated CaP deposited NF microsheets were used to
fabricate osteon-mimetic microtubes. The effect of the microtubular structure of CaPdeposited NF scaffolds on osteogenesis of MSCs and vascularization of endothelial
progenitor cells (EPCs) and MSC co-cultures was investigated. It was found that
microtubular

scaffolds

preferentially

supported

osteogenic

and

vasculogenic

differentiation of MSCs and MSCs/EPCs as evidenced by elevated gene expression level
of osteogenic and vasculogenic markers and enhanced calcium content, ALPase activity,
and total collagen secretion. The osteon-mimetic scaffolds developed in this research are
potentially useful as tissue engineered graft for regeneration of large bone defects.
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CHAPTER 1
INTRODUCTION
Cranial, maxillofacial, oral fractures and large bone defects are currently being
treated by using auto- and allografts. These techniques have limitations in the clinical
usage such as immune response, donor-site morbidity, and lack of availability [1-3].
Therefore, the interest on tissue engineering applications for bone graft procedures has
rapidly been growing. Among the 6 millions fractures occurring every year in the United
States, there are more than 0.5 million skeletal injuries that require bone graft
procedures [4]. Tissue engineering approach to bone graft application requires a cell
supporting scaffold in order to maintain a 3- dimensional substrate for cells to function
during the formation of bone tissue [5, 6]. The simple fractures in bone tissue can be
treated by standard conservative or surgical therapy. However, in some cases, such as
extended bone defects due to trauma or cancer resection bone grafting procedures are
being performed with engineered biomimetic materials [7, 8].
Bone tissue engineering scaffolds needs to provide several criteria in order to be
a successful candidate for bone graft procedures. An ideal scaffold should be completely
integrated with the surrounding bone tissue, support sufficient mechanical strength, and
function as a three dimensional framework for osteoprogenirator cells to fabricate bone

1

matrix. In order to integrate in bone defect site and provide adequate 3D structure,
scaffolds should fulfill following requirements: (a) should mimic physical and chemical
composition of the natural bone tissue, (b) should be biocompatible, (c) should be
porous to allow bone tissue organization and vascular formation, (d) should provide
appropriate surface chemistry and mechanical strength to support cellular attachment,
proliferation and differentiation and (e) should degrade simultaneously with the newly
grown bone tissue [9, 10].
The cortical bone composed of osteons that have microtubular structures with a
central vascular channel inside for ensuring suitable nutrient/waste transport to the bone
tissue [11]. The osteons are the structures form by laminated multilayers of apatite
nucleated aligned collagen nanofibers (NF). Mineralization of collagen NF is a wellregulated process mediated by many extracellular matrix proteins, such as bone
sialoprotein (BSP) and osteonectin (ON). These non-collagenous proteins contain a large
amount of glutamic acid (Glu) residues, which act as frameworks for depositing apatite
crystals on collagen fibers in nature bone [12-14].

The apatite crystals provide

mechanical strength for bone formation [15], while the collagen fibers provide structural
support and locations for cell adhesion and regulate cell functions such as cell adhesion,
proliferation, differentiation, and mineralization [16].
In order to develop biologically functional engineered bone tissue, it is important
to design scaffolds with micro- and nano-sized architecture similar to that of native bone.
Nanofibers (NFs) produced by electrospinning (ES) have attracted much attention
recently in tissue engineering applications [17]. Synthetic and natural polymers have been
electrospun into NFs with diameters ranging from tens of nanometers to a few
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micrometers. Due to their characteristics such as providing a large surface-to-volume
ratio and mimicking the natural extracellular matrix structure (ECM) of bone tissue, NFs
has been found to be a suitable scaffold for tissue engineering [18, 19]. However, poor
mechanical properties and relatively 2-dimensional (2-D) formation of electrospun NFs
limit their usage in bone tissue engineering applications. To overcome these limitations
of electrospun nanofibers, 3-D ceramic/polymer composite materials have been identified
for the preparation of bone tissue engineering scaffolds [20, 21]. The theory behind
designing such scaffolds is based on the osteon-mimetic mechanism of the unique
structure of HA/collagen in natural bone. Bone itself has a broad spectrum of mechanical
properties, depending on its type, humidity, mineral content, density, porosity, and
collagen fiber orientation [22]. The hierarchical organization between calcium phosphate
crystals and collagen fibers allows bone to possess both excellent bioactivities and
mechanical properties. Therefore, microtubular engineered 3-D biomaterials composed of
apatite-nucleated aligned NF would potentially provide temporary structural support to
the regenerating region, initiate osteogenic and vasculogenic differentiation, and degrade
simultaneously with the production of bone ECM. Consequently, the biomimetic
scaffolds aims to mimic the 3-D hydroxyapatite/collagen nanofibers structure of natural
bone.
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CHAPTER 2
BACKGROUND AND LITERATURE REVIEW
2.1 BONE TISSUE
Tissue is a group of cells which have similar functions in the body. Human body
consists of approximately 200 different types of cells which organized into four main
tissues: connective, epithelial, nervous and muscle tissues. Bones are composed of
connective tissues, which have extracellular matrix (ECM) in addition to the cells. Most
connective tissues have nerves and blood supply and consist of scattered cells submerged
in the ECM. The matrix contains structural networks and solutions of non-living
intracellular material. The matrix consists of different amount of fibers and ground
substances, which identify the character of the matrix. Bones are considered as
supporting connective tissues, which have a less diverse cell population compared to
other connective tissues. Bones are composed of a composite fibrous network collagen
encased within a hard matrix of calcium/phosphate. Mature bone matrix consist of
approximately 35% organic (collagen fibers, glycoproteins and proteoglycans) and 65%
inorganic material (hydroxyapatite, calcium carbonate and magnesium hydroxide). The
organic materials and mineral salts give bone its major characteristic function. Collagen
is responsible for the flexibility and resistance to being stretch, whereas the mineral salts
give the matrix compression strength. For instance, if all the mineral salts are removed
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from the bone matrix, bone becomes overflexible. On the contrary, if the collagen
removed from the bone, the bone will be more breakable [23-26].
Connective tissue originates from mesenchymal cells. Mesenchymal stem cells
(MSCs) have ability to diferentiate into more specialized cell arrays. Osteoprogenitor
cells are basic stem cells of bone structure. They have ability to become osteoblasts or
chondroplasts. Osteoprogenitor cells differentiate to osteoblasts if they are located close
to capillaries where oxygen concentration is high; otherwise they become chondroplasts
where they are far from capillaries. Bone cells can be categorized in four parts which
have all different functions and origins: osteoblasts, osteocytes, osteoclasts, and
osteoprogenitors. Osteoprogenitors are undifferentiated cells which will undergo mitosis
and develop into osteoblasts. They are usually found on the surfaces of bones and bone
cavities containing blood vessels and bone marrow. Osteoblasts grow from
osteoprogenitor cells located in the periosteum and the bone marrow. Osteoprogenitors
are induced to differentiate under the influence of growth factors, in particular the bone
morphogenetic proteins (BMPs). Osteoblasts have a large endoplasmic reticulum and
numerous ribosomes. They are derived from osteoprogenitor cells and produce collagen
and proteoglycans, which are stored by the Golgi apparatus and released from the cell.
The formation of bones by osteoblasts is called ossification or osteogenesis. The
interaction between osteoblasts forms the bone extracellular matrix (ECM) which
surrounds the cells. After an osteoblast starts to be surrounded by bone ECM, it becomes
an octeocyte. The majority of the bone cells are osteocytes, which derive from
osteoblasts, are found embedded in the bone matrix. Lacunae are the spaces that are
occupied by the osteocyte cell bodies and canaliculi are the spaces occupied by the
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osteocyte cell processes. Osteocytes do not secrete bone matrix. They only maintain the
matrix surrounding them in good condition. Osteoclasts are large cells with more than
one nuclei. They are responsible for resorption of bone. Osteoclasts produce some
enzymes which help breaking down the bone ECM. This function of the osteoclasts is
important in the development, growth, maintenance and repair of bone [23, 24, 26, 27].

Figure 2.1 Bone Cells [24]
2.2 BONE STRUCTURE AND FUNCTIONS
Bone tissues consist of osteocytes scattered in a hard calcified matrix. Each bone
in the skeleton has two different forms of osteon tissue: compact bone and spongy bone.
Compact bone is relatively solid; however, spongy bone has a smooth structure. Compact
bone consists of closely packed microscopic cylindrical structures called osteons. The
matrix and osteocytes of the osteon are laid down in concentric rings around a central
(Haversian) canal that contains blood vessels and nerves. Fine cellular extensions connect
osteocytes within an osteon to each other and to the Haversian canal. Nutrients and
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wastes are exchanged between the osteocytes and the blood vessels through these cellular
extensions. Blood vessels which run through the central canals are connected to the blood
vessels in the periosteum that surrounds the bone by perforating canals called
Volkmann’s canals. Compact bone tissues make up the shaft of long bones and are
located at the outside surface of other bones. Spongy bone consists of an irregular
latticework of thin plates of bone called trabeculae. Blood vessels and red marrow, which
produces blood cells, fill the spaces between trabeculae. These blood vessels are
connected to blood vessels found in the Volkmann’s and Haversian canals. In contrast to
compact bone, spongy bone does not contain osteons and is found inside the bones.
Compact bones are located on the surface of a bone to protect the bone structure, whereas
spongy bones are located inner part of the bone. Bones are the framework for supporting
the attachment of muscles and other tissues. Besides, bone protect internal organs from
outside effects such as the skull protecting the brain or the ribs protecting the heart and
lungs. Bones work together with skeletal muscles, tendons, ligaments and joints for body
movement. The red marrow which is within the medullar cavity of long bones produces
red blood cells. Bones are storage of several essential minerals such as calcium and
phosphorus, and help kidney for arranging acid-base balance by absorbing or releasing
alkaline salts [23, 26, 27].
2.3 BONE TYPES
There are five types of bones in the human body: long, short, flat, irregular,
sesamoid, and sutural bones. Long bones are much greater in length than width such as
limbs, fingers and toes. Long bones consist of a shaft (diaphysis) and two extended ends
(epiphysis). The diaphysis is made out of compact tissue surrounding a central cavity
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which is called medullar cavity. Epiphysis contains spongy bones and red marrow and it
is covered by thin layer of compact tissue. Hyaline cartilage overlaps the epiphysis on its
outer surface. The periosteum covers the outside of the long bone. Short bones have a
structure similar to long bones. Examples of short bones include carpal bones and tarsal
bones. Flat bones, which form the roof of the skull, the sternum, the ribs and the scapula,
have thin, severally parallel surfaces. Protection of underlying soft tissues and providing
the surface area for muscles attachment are basic functions of flat bones. Irregular bones
have complex shapes. They are located at several skull and spinal vertebra. Sesamoid
bones are small, flat, and shaped like sesame seeds. They are located near joints on the
knees, the hands and the feet. Sutural bones are small, flat, irregularly shaped bones
between the flat bones of the skull [23, 26].

Figure 2.2 Classification of Bones [23].
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2.4 BONE DEVELOPMENT AND GROWTH
The size and proportions of our body are determined by the growth of the
skeleton. After 6 weeks from fertilization, the bone skeleton starts forming. Bones keep
growing through adolescence until age 25. Bone might develop from mesenchymal cells
or by the replacement of cartilage. Ossification, which refers to the formation of bone, is
the process of replacement from other tissues to bone tissue. Calcification is the
deposition of the calcium salts. There are two forms of ossification: intramembranous and
endochondral ossification. In intramembranous ossification, mesenchymal cells and
fibrous connective tissue are the major source of bone tissue. In endochondral
ossification, bone differentiates from existing cartilage [23, 26].
Intramembranous ossification starts when osteoblasts differentiate within a
mesenchymal or fibrous connective tissue and occurs in the deeper layers of the dermis.
Embryonic mesenchyme condenses around the developing brain to form a membrane of
connective tissue with oriented, delicate fibers. Osteoprogenitor cells differentiate to
osteoblasts, which produce bone matrix to surround the aligned collagen fibers. After that
process, many trabeculae of woven bone are formed. The rest of osteoblasts gather close
to the surface of the trabeculae and produce larger trabeculae. Trabeculae join together to
be able to develop cancellous bone. The cells, which are located in the inner part of
cancellous bone, develop red bone marrow. After cancellous bone is developed, the cells
that surround the outer part of the bone form periosteum. Osteoblasts develop the
periosteum and bone matrix to form the outer surface of the compact bone. Endochondral
ossification begins with the formation of hyaline cartilage at the end of the fourth week of
development. The mesenchymal cells differentiate to chondroplasts. Chondroplasts
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develops a hyaline cartilage having the original shape of the bone. After chondroplasts
are surrounded with cartilage matrix they become chondrocytes, which is surrounded
with perichondrium. After blood vessels are connected to perichondrium, osteoprogenitor
cells become osteoblasts and begin producing the bone structure. As osteoblasts keep
producing bones, perichondrium turns out to periosteum [23, 26, 27].
2.5 BONE SUBSTITUTES
Bone graft substitutes are required to repair the injuries that are extremely hard
for the body to cure by using the bone repair process. Approximately 500.000 bone grafts
operations are made annually in the United States. There are basically three major
methods of bone substitute usage in medical applications. Autografting, which comprises
58% of the current bone substitutes, is a graft made of bone from the patient’s own body.
An example for one of the most commonly performed bone autograft is being used in
spinal fusion. In a fusion procedure, bone graft from the patient's hip is implanted in disc
spaces between spinal vertebrae or along the back of the spine. The grafted bone fuses the
vertebrae together over several months. Allografting, which represents about 34% of the
current bone substitutes, contains harvesting and processing bone from a cadaver then
transplanting it to the patient. Allogenic implants are acellular and are less successful
than autografts for immunogenicity and the absence of viable cells that become
osteoblasts. Another disadvantage of allografting is high risk of transmitted diseases.
Man-made materials such as metals, plastics, and ceramics represent approximately 8%
of bone substitutes. These materials, however, are subject to fatigue, fracture, toxicity,
and wear, and do not remodel with time, such as a metal bone implant, which cannot
grow with the patient and it cannot change shape in response to the loads placed upon the
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implant. For all these reasons, there is an increasing need for alternative bone substitutes
and better wound healing therapies. The numerous research have been done on
engineering natural or synthetic scaffolds to make them suitable for bone regeneration
applications. The main idea of bone tissue engineering is to develop similar structural and
functional properties of the bone ECM [26-28].
2.6 BONE TISSUE ENGINEERING
Tissue Engineering is an interdisciplinary field that combines the principles of
biology and engineering to mimic human tissues. The general requirements for developed
scaffolds are easy handling and applying, being readily adherent, having appropriate
mechanical

and

physical

properties,

being

non-toxic,

non-antigenic,

sterile,

osteoconductive, cost effective, and undergoing controlled degradation. Tissue
engineering techniques involve mimicking the natural bone structure by placing the cells
and growth factors in synthetic scaffolds that act as temporary bone ECM [26, 28]. The
major function of a degradable scaffold is to support the transplanted tissues. There are
many kinds of biomaterials being used for bone tissue engineering applications such as
natural and synthetic polymers, ceramics, and composites [26, 29].
2.7 BIOMATERIALS FOR SCAFFOLD FABRICATION
Natural and synthetic materials have been investigated as a matrix for
biomimetic scaffold fabrication in bone tissue engineering [30]. Natural materials
provide a conductive matrix for cell migration and adhesion since they include the
biological cues but they are lack of sufficient mechanical strength to prevent soft tissue
compression [31]. Synthetic materials could be designed with defined physical and
mechanical properties, but they lack bioactive cues to support cell−matrix interactions
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required for adhesion, proliferation, and differentiation. Therefore, an ideal scaffold
must provide the optimum structural parameters, conductivity to the cellular activities;
these include cell penetration and migration into the scaffold, cell attachment onto the
scaffold substrate, cell spreading and proliferation.
One of the first considerations when designing a scaffold for bone tissue
engineering is the choice of material [32, 33]. In order to mimic the mineralized
nanofibrous structure of natural bone tissue, two main material types; natural polymers
and synthetic polymers, and their composite structures with hydroxyapatite have been
successfully investigated for biomimetic scaffold fabrication.
2.8 NATURAL POLYMERS
Natural polymers, which commonly derived from protein or carbohydrate
polymers, can be considered as the first biodegradable scaffolds used clinically in bone
tissue engineering applications [34]. These polymers have a number of advantages such
as outstanding biocompatibility, relative abundance, and biodegradability. However, the
batch-to-batch variations in the structure, insufficient mechanical strength and risk of
immunogenic effect when implanted require using natural polymers with some
modifications. Here, we focus on most widely used natural polymers; collagens,
chitosan and gelatin, which can be fabricated in fibrous structure and their composite
structures by incorporating calcium phosphate crystal for bone tissue engineering
applications [35].
Since collagen is the major protein in bone extracellular matrix, it is considered
by many researchers as an ideal scaffold for tissue engineering applications [35].
Twenty-seven types of collagens have been identified so far, but collagen type I is the
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most investigated one since it is the most abundant collagen in bone tissue [36]. The
functions of collagen are providing support to connective tissues such as skin, tendons,
bones, cartilage, blood vessels, and ligaments [37, 38], transduces essential signals for
the regulation of cell anchorage, migration, proliferation, differentiation, and survival
[39]. Bone tissue engineering scaffolds requires high mechanical strength for in vivo
applications of the scaffolds. Therefore, scaffolds for bone tissue engineering require
hardening of a collagen biomaterial by mineralization [22, 40] or combining with
hydroxyapatite crystals [41, 42]. Recently, a broad range of bone tissue engineering
products based on collagen scaffolds have been developed. For example, Xiao et al.
fabricated three-dimensional type I collagen based scaffolds and seeded with
osteoprogenitor cells and implanted into critical-size bone defects in skulls of
immunodeficient (SCID) mice. They have shown new bone formation at the critical
defect site after 28 days [43]. Chan et al. developed a collagen microencapsulation
technology by encapsulating bone marrow–derived mesenchymal stem cells (MSCs) in a
biomimetic collagen fiber meshwork and investigate the differentiation capacity of the
MSCs. The differentiation of MSCs was confirmed with significantly increased calcium
content and alkaline phosphatase activity in the collagen microspheres [44]. In addition,
there are some developed collagen based scaffolds in the market that have been used as
bone grafts. For example, a mixture of porous hydroxylapatite and tricalcium phosphate
and collagen I was fabricated by Angiotech Pharmaceuticals, Inc. and have been used
clinically for healing large bone defects. Furthermore, hydroxyapatite coated collagen
fibers developed by DePuy Orthopaedics has been approved for clinical use as a bone
graft substitute in spinal fusions [39].
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Chitosan the second most abundant natural polymer is produced from chitin,
which is a natural polysaccharide found in crab, shrimp, lobster, coral, jellyfish,
butterfly, ladybug, mushroom and fungi [45]. Chitosan can be easily modified into
various forms such as films, fibers, and more complex shapes for bone tissue
engineering applications [46]. However, chitosan based scaffold by itself cannot support
load bearing bone grafts. Developing composite matrix by combining calcium phosphate
crystals with chitosan based scaffolds improve the mechanical properties of chitosan and
make it suitable for bone tissue engineering applications [46, 47]. For example, Zhang et
al. developd a novel biomimetic nanocomposite nanoﬁbers of hydroxyapatite/chitosan
(HAp/CTS) and seeded with human fetal osteoblast (hFOB) cells for up to 15 days. The
results demonstrated that incorporation of HAp nanoparticles into chitosan nanoﬁbrous
scaffolds shows significant higher mineral deposition compared to pure electrospun CTS
scaffolds [48]. Thein-Han et al. and Teng et al. prepared biomimetic CTS/HA composite
membranes and seeded with pre-osteoblasts (MC 3T3-E1) cells. Cell culture
experiments demonstrated that CTS/HA composite scaffolds are potential candidate
materials for bone regeneration [49, 50].
Gelatin is a natural polymer that is derived from collagen by hydrolysis, and is
commonly used for pharmaceutical and tissue engineering applications because of its
biodegradability and biocompatibility in physiological environments [51, 52]. Since
gelatin is a denatured format of collagen, it has relatively low antigenicity compared to
other natural polymers [38]. Gelatin-based composites with incorporation of calcium
phosphate crystals, therefore, provide an alternative scaffold for bone tissue engineering
applications. For example, Takahashi et al. fabricated biodegradable gelatin sponges

14

incorporating β-tricalcium phosphate (βTCP) (gelatin-βTCP) and investigated the in
vitro osteogenic differentiation of MSCs isolated from the rat bone marrow. The alkaline
phosphatase activity and osteocalcin content results demonstrated that osteogenic
differentiation of MSCs occured when seeded on gelatin-βTCP sponges [53]. Xia et al.
investigated the potential application of bone marrow stromal cells (BMSCs) and an
injectable sodium alginate/ gelatin scaffold for bone tissue engineering (BTE). The
phenotype of osteogenic BMSCs was examined by mineralized nodules formation and
type I collagen expression. They showed that sodium alginate/ gelatin scaffold promoted
the bone formation and bone healing when implanted in the rabbit calvarial critical-sized
defect [54]. He et al. fabricated three-dimensional mineralized (3-D) porous gelatin
scaffolds and seeded with MC3T3-E1 pre-osteoblastic cells. The results inticated that
the MC3T3-E1 cells grown on the mineralized gelatin scaffolds showed higher levels of
ALP activity and osteocalcin expression than that on the neat gelatin scaffold [55]. Liu
et al. fabricated nanofibrous gelatin/apatite (NF-gelatin/apatite) composite and seeded
with pre-soteoblastic cells. They were demonstrated that the expression of bone
sialoprotein and osteocalcin in the osteoblast–(NF-gelatin/apatite composite) constructs
was about 5 times and 2 times higher than in the neat gelatin constructs after four weeks
of cell culture [56]. Besides the direct implantation into bone defect site, gelatin has also
been used as controlled-release devices of basic fibroblast growth factor (bFGF),
transforming growth factor-h1 (TGF-β1), bone morphogeneticprotein-2 (BMP-2) growth
factors which have specific function on enhancing bone formation [57, 58].
Overall, as the previous studies indicated the disadvantage of using insufficient
mechanical strength natural polymers could be improved by combining with calcium-
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phosphate (CaP) based crystals and make them suitable for bone tissue engineering
applications.
2.9 SYNTHETIC POLYMERS
Synthetic polymers based scaffolds have some advantages compared to natural
polymers such as reproducibility, unlimited supply, relative lack of immunogenic effect,
and tunable properties such as degradation rates and mechanical strength. Synthetic
polymers used for bone regeneration include poly(lactic acid) (PLA), poly(glycolic acid)
(PGA), poly(lactic-co-glycolic) acid (PLGA), polypropylene fumarate (PPF), and the
polyhydroxyalkanoates (PHAs) [59]. Combining polymers with hydroxyapatite creates
biomimetic scaffolds that enhance bone tissue formation.
Poly lactic acid (PLA) is a biodegradable polyester synthesized by polycondensation of lactic acid, and amonomeric precursor that can be obtained from
renewable resources. Lactic acid is a chiral molecule available in the L and D
stereoisomer forms. Since L-lactic acid occurs in the metabolism of all animals and
microorganism, it’s degradation products are completely non-toxic [60, 61]. PLA based
scaffolds are biodegradabile, biocompatibile, and have suitable mechanical properties,
and ability to be dissolved in common solvents for processing. Due to these features,
PLA has been successfully used for bone tissue engineering applications [61]. For
example, Liao et al. fabricated a composite scaffold consisting of nano-HA/collagen and
seeded with osteoblasts isolated from rat. Then, the composite scaffold was implanted
into critical size defect in rabbit. The results showed that osteoblasts adhered, spread, and
proliferated throughout the pores of the scaffold within a week and the implanted
composite was partially substituted by new bone tissue after 12 weeks [62]. Our group
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also produced random and aligned PLA nanofibers via electrospinning technique and
seeded with rat MSCs. We investigate the effect of fiber alignment on osteogenic
differentiation of MSCs. The results indicated that BMS cells aligned in the direction of
PLLA fibers to form long cell extensions, and fiber orientation affected the extent of
mineralization, but it had no effect on cell proliferation or mRNA expression of
osteogenic markers.
Poly (glycolic acid) (PGA) and poly (lactic acid) (PLA) are biodegradable
synthetic polymers, which can react to form the copolymer poly (lactic-co-glycolic acid)
(PLGA). The main advantage of PLGA is that the ester bonds that make up the backbone
of the polymer can be hydrolyzed, causing the scaffold to degrade into metabolite
nontoxic by-products. These by-products can be absorbed by the body and may cause pH
changes around the implantation site. In addition, the degradation profile of PLGA can be
controlled by changing the ratio of PGA to PLA in the scaffold [63]. These feature make
PLGA based scaffolds a good candidate for bone tissue engineering applications. For
example, Lao et al. fabricated PLGA/HA nanofibers composite by electrospinning and
seeded with neonatal mouse calvaria-derived MC3T3-E1 osteoblasts. The results showed
that composite scaffolds could support cell adhesion and proliferation [64].
Polycaprolactone (PCL) has low melting point of around 60°C and a glass
transition temperature of about −60°C. PCL can be degraded by hydrolysis of its ester
linkages in physiological conditions and has high mechanical strength compared to most
of the synthetic polymers. Due to these features, PCL has been widely used in bone tissue
engineering applications [65]. For example, Shin et al. produced highly porous,
degradable PCL scaffold by electrospinning, seeded with rat MSCs, and cultured in a
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rotating bioreactor for 4 weeks. The scaffold then implanted into the omenta of rats for 4
weeks. The results showed bone like tissue formation on the implant site [66]. In another
study, Venugopol et al. fabricated (PCL/nHA/Col) biocomposite nanoﬁbrous scaffolds to
provide mechanical support and seeded with human fetal osteoblasts (hFOB). They
indicated that the nanoscale biocomposite scaffold supported hFOB adhesion, migration,
proliferation and mineralization to form a bone tissue for the regeneration of bone defects
[67].
2.10 CALCIUM PHOSPHATE CERAMICS
Calcium phosphate (CaP) ceramics have also been used to synthesize biomimetic
scaffolds for bone tissue engineering. The main purpose to use CaP ceramic is that CaP
is abundantly found in bone tissue and it shows biocompatibility, and osteoconductivity.
However, the major drawbacks for using CaP ceramics are low mechanical stability and
the inability to control the pore size and chemical composition. The most widely studied
CaP ceramics are tricalcium phosphate (TCP), hydroxyapatite (HA, Ca10(PO4)6(OH)2),
and tetracalcium phosphate [68]. Although several studies have shown bone
regeneration with CaP based scaffold implantation, the feature of being highly brittle
prevents using CaP ceramics for bone defects [21, 69]. In order to overcome these
drawbacks of using CaP ceramics by itself as a scaffold, combination of natural or
synthetic polymers with CaP ceramics have been used for bone tissue engineering
applications.
2.11 FABRICATION TECHNIQUES OF BIOMIMETIC FIBROUS SCAFFOLDS
In order to mimic the three-dimensional structure of natural bone tissue,
biomimetic scaffolds must facilitate the cell distribution and guide their growth into
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three-dimensional space. Collagen nanofibers in natural bone tissue have fibrous
structure with diameter range of from 50 to 500 nm [70, 71]. The ideal biomimetic
scaffolding techniques should allow fabricating the nanofibrous structure of collagen
nanofibers in natural bone. Several methods have been developed to fabricate
nanofibers, such as self-assembly [72], phase separation [73], and electrospinning [74,
75].
Self assembly is the organization of the molecule into an ordered structure
required for specific function (Zhang, 2003). The structure of the self assembled
molecules are maintained by non-covalent bonds such as hydrogen bonds, ionic bonds,
and hydrophobic interactions [76] . Peptides and proteins can be self assembled to form
nanofibrous well-defined functional structures [77, 78]. The advantage of the self
aseembly technique over phase separation and electrospinning is producing much
smaller nanofibers. However, the drawbacks of low mechanical strength and limited
macroporous structure of self assembled peptides prevents them to be ideal biomimetic
scaffold for bone tissue engineering applications.

Figure 2.3 Molecular models of self-assembling peptides [79]

19

Figure 2.4 Schematic of the electrospinning process [80]
The electrospinning technique for the scaffold fabrication uses the electrostatic
force for the production of polymeric fiber ranging from nanoscale to microscale. In the
electrospinning process, the use of a high voltage electrostatic field to charge the surface
of a polymer solution droplet induces the ejection of a liquid jet through a spinneret.
Applied electrical field between a droplet of a polymer solution, which is held in the
syringe, and a grounded target makes the polymer solution to be ejected when the applied
electric field overcomes the surface tension of the polymer solution. During the ejection,
solvent in the polymer solution evaporates, and electrospun nanofibers are collected on
the grounded collector [80-85]. System and process parameters are the two sets of
parameters that affect the process of electrospinning. System parameters such as polymer
molecular weight and distribution determine the rate of nanofiber degredation. Polymer
solution properties such as viscosity, surface tension, and conductivity, determine the
nanofiber diameter. Process parameters such as orifice diameter, flow rate of polymer,
and electric potential also have significant influence on fiber diameter. Process
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parameters such as distance between syringe and metal collector determine the extent of
evaporation of solvent from the nanofibers and deposition on the collector [80, 85, 86].
Electrospinning has been used to produce nanofibers (NFs) [17] from natural
biopolymers, like collagen and chitosan, or synthetic polymers such as poly(L-lactide)
(PLLA) and poly(ε-caprolactone) (PCL) [78, 87-89]. Among these fabrication techniques
of fibrous biomimetic scaffolds, electrospinning has been regarded as the most promising
approach to fabricate nanofibers with adjustable fiber diameter from nanometer to
micrometer [87].The advantages of this technique is that it can produce nanofibers that
can provide high surface-area-to-volume ratio, similar morphology to the collagen
nanofiber in natural bone, degradability, biocompatibility, and high mechanical strength
for cell adhesion, proliferation and differentiation [90, 91]. These characteristics are
favorable for better cellular growth and tissue organization for in vitro and in vivo bone
tissue engineering applications [18, 92].

Figure 2.5 SEM micrographs of (a) random and (b) aligned fibers, electrospun from 9.0
wt % PLLA in HFIP solvent. The diameter and rotation speed of the collecting wheel
were 20 cm and 1200 rpm, respectively [93].
Phase separation technique for fibrous scaffolds fabrication relays on
temperature change that separates the polymeric solution in two phases, one having low
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polymer concentration (polymer lean phase) and other having the high polymer
concentration (polymer rich phase) [94]. Phase separation process for nanofiber
formation consists of five steps: polymer dissolution, phase separation and gelation,
solvent extraction, freezing, and freeze-drying under vacuum [70]. The fiber network
formation depends on the solvent of the polymer solution and the gelation temperature.
The fibers formed in this manner have diameters ranging from 50–500 nm, and have a
porosity in excess of 98% [56, 70]. The advantage of the phase separation technique is
that it can be combined with other processing techniques such as particulate leaching to
fabricate biomimetic scaffolds with well-defined pore morphologies [95].

Figure 2.6 Schematics of phase separation for obtaining nanofibers structure [96].
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2.12 DESIGNING OF BIOMIMETIC SCAFFOLDS
The limitation of using synthetic biodegradable polymers as biomimetic
scaffolds is that they cannot promote cell adhesion, proliferation, and differentiation as
much as natural polymer because they often lack of biological cues. Although growing
hydroxyapatite on synthetic scaffold improves osteoconductivity and cellular
interactions, further surface modifications should be done to completely overcome the
problem of limited cell recognition points. For example, Langer et al. synthesized
poly(L-lactic acid-co-L-lysine) and conjugated Arg-Gly-Asp (RGD) peptide to the
lysine residue of the copolymer to enhance cell adhesion. The RGD peptides of ECM
proteins interact with MSCs through integrin surface receptors to facilitate cell
spreading and adhesion. The results demonstrated that cell spreading mean area was
significantly increased on scaffolds with RGD peptide [97, 98]. Hu et al. fabricated
RGD peptide attached porous poly(lactic acid) (PLA) scaffolds and seeded with
osteogenic precursor cells to investigate the RGD peptide attachment on cell
proliferation and differentiation. The results of this study indicated that RGD peptide
attachment to the surface of PLA polymer scaffolds enhances cell attachment and
differentiation [99]. Our group recently produced RGD and bone morhogenic peptide-2
(BMP-2) grafeted Poly (lactide-co-ethylene oxide-co-fumarate) (PLEOF) based
hydrogels and investigate the effects of RGD and BMP peptide on osteogenic
differentiation and mineralization of MSCs. Our results demonstrated that RGD and
BMP peptides, grafted to a hydrogel substrate, act synergistically to enhance osteogenic
differentiation and mineralization of MSCs [100].
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The function of calcium phosphate crystals (mainly hydroxyapatite) in a
composite scaffold is providing good osteoconductivity while the fibrous structure of
natural or synthetic polymer supports design flexibility to achieve the high porosity and
high surface area for cell survival and differentiation [56, 70]. Zhang et al. and Ma et al.
developed highly porous poly(L-lactic acid) (PLLA) and PLLA/hydroxyapatite (HAP)
composite scaffolds with a thermally induced phase separation technique and seeded
with osteoblastic cells. The proliferation of osteogenic cells and expression of bone
sialoprotein and osteocalcin were significantly higher in the PLLA/HAP composite
scaffold than in the PLLA scaffolds [98, 101]. Marra et al. fabricated hydroxyapatite
incorporated biodegradable poly(caprolactone) and poly(D,L-lactic-co-glycolic acid)
scaffolds by solvent-casting followed by particulate-leaching technique and seeded with
rabbit bone marrow stromal cells . They have shown bone extracellular matrix formation
(approximately 20% tissue ingrowth) after 8 weeks of in vitro culture [102]. In
particulate leaching technique, defined shape salt particules are poured into a mold with
hydroxyapatite crystals and polymer solution. Polymer solution is then cast into the saltfilled mold. After the evaporation of the solvent, the salt crystals are leached away using
water to form the pores of the scaffold [103].
Many biomimetic approaches to mineralization involve soaking a polymer
construct in simulated body fluid (SBF), a type of medium with ion concentrations
approximately similar to human plasma. Different composition of SBF such as 1xSBF,
5xSBF, and 10xSBF, indicating the molar ratio of the components relative to body fluid,
have been developed in order to deposit different structure of CaP crystals and reduce
the duration of biomineralization [104-106]. For example, Cowan et al. fabricated
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mineralized poly(lactic-co-glycolic acid) (PLGA) scaffolds by soaking the scaffold into
5xSBF and seeded with BMS cells. They have shown that mineralized PLGA scaffolds
produced new bone formation after 4 weeks; however, the non-mineralized scaffolds did
not show any bone formation at the same time point [107].
Most of the fabricated scaffolds have inert surface that does not allow
biomineralization when incubating in the SBF. Therefore, research in the area of
biomimetic mineralization has been mainly focused on the surface modification of the
scaffolds. Several surface modification methods have been developed for enhancing CaP
deposition [108, 109]. For example, Kim et al. functionalized the surface of Titanium (Ti)
by hydroxylation which forms Ti-OH groups on the surface and immered into SBF to
investigate the surface modification on bone-like apatite deposition. The results indicated
that the Ti-OH groups enhanced the formation of apatite on the Ti alloys [110]. Yang et
al. fabricated electrospun polycaprolactone (PCL) scaffold and functionalized with
plasma surface treatment to replace the weak chemical bonding of PCL with highly
reactive carbonyl (–CO–), carboxyl (–COOH) and hydroxyl (–OH) groups. They
demonstrated that there was significantly higher CaP nucleation on the surface
functionalized PCL scaffolds [109, 111]. Murphy et al. functionalized the surface of
PLGA by hydrolysis, which increases the amount of surface carboxyl and hydroxyl
groups due to scission of polyester chains. The availability of carboxyl and hydroxyl
groups enhanced the apatite growth [112] .The functionalized surfaces of the biomimetic
scaffolds act as an anologus template of osteonectin and bone sialoprotein, which have
highly glutamic acid and aspartic acid residues and function on mineralization in natural
bone. Therefore, in order to mimic the biomineralization occurs in natural bone tissue
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our group has done several studies. We synthesized osteonectin-derived peptide
containing 6-glutamic acid sequence by solid phase peptide synthesis.

In order to

covalently attach the peptide to in situ crosslinkable PLEOF hydrogel, one end of the
synthesized peptide was functionalized with an acrylate group. We investigated the effect
of osteonectin derived peptide on the viscoelastic properties of PLEOF/apatite composite.
The results demonstrated that the osteonectin derived peptide significantly affects the
shear modulus of the scaffold because of ionic interactions between the peptide and HA
crystals [12, 13].
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EFFECT OF SURFACE MODIFICATION OF NANOFIBERS WITH GLUTAMIC
ACID PEPTIDE ON CALCIUM PHOSPHATE NUCLEATION AND OSTEOGENIC
DIFFERANTIATION OF MARROW STROMAL CELLS
Ozan Karaman, Ankur Kumar, Seyedsina Moeinzadeh, Xuezhong He, Tong Cui, Esmaiel
Jabbari
3.1 INTRODUCTION
Bone is a composite matrix composed of mineralized aligned collagen nanofibers
[113]. Combination of inorganic apatite nanocrystals and organic collagen fibers provides
bone with unique mechanical and biological properties [15, 114]. The apatite
nanocrystals provide osteoconductivity and stiffness while the collagen fibers provide
elasticity and a template for mineralization and maturation of osteoprogenitor cells.
Unique factors that contribute to bone toughness are the aligned network of collagen
fibers, apatite nanocrystals, and proteins in the bone extracellular matrix (ECM) that link
the apatite crystals to the collagen fibers. In an effort to mimic the morphology of the
ECM, electrospinning has been used to produce aligned nanofibers (NFs) [17] from
natural biopolymers, like collagen and chitosan, or synthetic polymers such as poly(Llactide) (PLLA) and poly(ε-caprolactone) (PCL) [78, 87-89]. Due to their nano-scale size
and
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alignment, electrospun NFs provide enormous surface area for cell adhesion, migration,
and differentiation [115].
Different methods are used to create a composite of nanofibers reinforced with
calcium phosphate (CaP) crystals to improve mechanical strength and provide a
conductive matrix for osteoprogenitor cells [116, 117]. In one approach, CaP
nanocrystals were mixed with the spinning solution and the solution was electrospun to
form CaP composite NFs [118, 119]. In that approach, CaP loading and strength of the
composite were limited by viscosity of the spinning solution. In another approach,
electrospun nanofibers were laminated with a CaP paste to form a composite sheet [120].
This approach was limited to CaP pastes and toughness of the composite depended on the
extent of penetration of the paste in the fiber mesh. In a biomimetic approach, NFs were
coated with CaP crystals by incubation in a modified simulated body fluid [106, 121123]. The latter approach mimicked the morphology of the mineralized bone matrix but
drawbacks included diffusion-limited penetration of calcium and phosphate ions in the
central part of the fiber sheet and crystal nucleation on the fiber surface.
Nucleation, growth, and stabilization of CaP nanocrystals on collagen fibers in the
bone matrix is mediated by ECM non-collagenous proteins such as bone sialoprotein
(BSP), osteonectin (ON), osteopontin (OP) and osteocalcin (OC) [12, 78, 124]. GLU
sequences ranging from 2-10 residues in those proteins regulate nucleation and growth of
CaP crystals on collagen fibers [124]. The objective of this study was to investigate the
effect of calcium phosphate (CaP) deposition on aligned nanofibers surface-modified
with a glutamic acid peptide (GLU) on osteogenic differentiation of rat marrow stromal
cells (MSCs). In that regard, the peptide EEGGC consisting of two glutamic acids
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terminated with a cysteine functional group at one end and two glycine residues at the
other end was conjugated to low molecular weight polylactide macromer. The
synthesized PLA-GLU polymer-peptide conjugate was blended with high molecular
weight poly(lactide-co-glycolide) (PLGA) polymer and the blend was electrospun to
form aligned nanofibers surface-modified with GLU peptide (GLU-NF). The GLU-NF
microsheets were incubated in a modified simulated body fluid (SBF) for GLU-mediated
nucleation and growth of CaP crystals on the fiber surface. To achieve a high CaP to fiber
ratio, a layer-by-layer approach was used to improve the diffusion of calcium and
phosphate ions inside the microsheets. The effect of GLU-mediated CaP deposition on
aligned nanofibers on osteogenic differentiation of rat MSCs was investigated by
cytochemical,

mRNA

expression,

and

immunocytochemical

analysis.

Results

demonstrate that surface modification of nanofibers with GLU peptide dramatically
increased nucleation and growth of CaP nanocrystals on the fiber surface, leading to
significantly higher differentiation of MSCs and mineralized matrix formation.
3.2 MATERIALS AND METHODS
3.2.1. SYNTHESIS AND CHARACTERIZATION OF PLA-GLU CONJUGATE
Cysteine-terminated EEGGC peptide was synthesized manually on Rink Amide
NovaGelTM resin (EMD Biosciences, San Diego, CA) in the solid phase and
functionalized by the addition of a cysteine residue at the glycine end using a previously
described procedure [125-127]. Briefly, the Fmoc-protected amino acid (6 equiv), N,N′di-isopropylcarbodiimide

(6.6

equiv,

DIC,

Acros,

Pittsburgh,

PA)

and

hydroxybenzotriazole (12 equiv, HOBt, Acros) were added to 100 mg resin and swelled
in N,N-Dimethylformamide (DMF, Acros). Next, 0.2 mL of 0.05 M N,N-
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dimethylaminopyridine (DMAP, Acros) was added to the mixture and the coupling
reaction was allowed to proceed for 4-6 h at 30ºC with orbital shaking. The resin was
tested for the presence of unreacted amines using the Kaiser reagent [128]. After coupling
the last amino acid, the EEGGC peptide was cleaved from the resin and precipitated in
cold ether. The peptide was purified by preparative HPLC and characterized by Finnigan
4500 Electro Spray Ionization (ESI) spectrometry (Thermo Electron, Waltham, MA) as
described [127]. A similar procedure was used to synthesize EEGGKC peptide.
L-lactide

(LA; >99.5% purity; Ortec, Easely, SC) monomer was dried under

vacuum at 40°C for at least 12 h prior to the reaction. Low molecular weight poly(Llactide) (LMW-PLA) was synthesized by ring-opening polymerization of LA monomer
as previously described [125, 129]. Diethylene glycol (DEG, Fisher, Waltham, MA) and
tin (II) 2-ethylhexanoate (TOC, Sigma-Aldrich) were used as the polymerization initiator
and catalyst, respectively. The molar ratios of DEG:TOC and LA:DEG were 20:1 and
10:1, respectively. After the reaction, double precipitation in two non-solvents, diethyl
ether and hexane, was used to fractionate and isolate the LMW-PLA [125]. The
synthesized polymer was characterized by gel permeation chromatography (GPC) and
1

H-NMR as described [125]. Next, the LMW-PLA chain was terminated with an

acrylamide group by reaction with acryloyl chloride (Ac, Sigma-Aldrich). In a typical
reaction, 20 g LMW-PLA was dissolved in 150 mL dichloromethane (DCM, Acros)
under dry nitrogen atmosphere. After cooling to 5°C, 0.6 mL Ac and 1.55 mL
triethylamine (TEA, Sigma-Aldrich), each dissolved in DCM, were added drop-wise to
the reaction with stirring. The reaction continued for 6 h on ice followed by 12 h under
ambient conditions. After the reaction, solvent was removed and residue was dissolved in
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anhydrous ethyl acetate to precipitate and remove the byproduct triethylamine
hydrochloride. The Ac-PLA product was precipitated twice in hexane and cold ether, and
dried in vacuum. The

and polydispersity index of the Ac-PLA were 5.3 kDa and 1.2,

respectively.
EEGGC peptide was conjugated to Ac-PLA by Michael addition reaction between
the cysteine’s sulfhydryl group on the peptide and the acrylate group on the polymer to
produce the PLA-GLU conjugate. Briefly, the peptide dissolved in sodium borate buffer
(pH 8.5), was added to a solution of Ac-PLA in DMF (2:1 peptide:Ac-PLA molar ratio)
and allowed to react for 12 h at 30°C in an orbital shaker. The solution was then dialyzed
(MW cutoff 3.5 kDa, Spectrum Laboratories, Rancho Dominquez, CA) against distilled
deionized (DI) water and lyophilized to obtain the dry PLA-GLU conjugate. The
chemical structure of the conjugate was characterized by 1H-NMR.
3.2.2 PLGA/PLA-GLU FIBER SPINNING
PLGA sample (Durect, Pelham, AL) was a 50/50 copolymer of D,L-lactide and
glycolide monomers with intrinsic viscosity of 1.1 dL/g and weight average molecular
weight of 105 kDa. A blend of 10 wt% high molecular weight PLGA and 1.5 wt% PLAGLU was dissolved in 1, 1, 1, 3, 3, 3-hexafluoro-2-propanol (HFIP, VWR, West Chester,
PA) solvent. A programmable KDS100 syringe pump (KD Scientific, Holliston, MA)
was used to transfer and inject the polymer solution from a 1 mL syringe through a 21gauge needle. The needle was connected to the positively charged Pt electrode of a high
voltage power supply (ES40P-5W/DAM, Gamma High Voltage Research). A custombuilt aluminum rotating wheel (20 cm diameter and 5 mm thickness), powered by a highspeed DC motor ((2M0578, Dayton Electric, Niles, IL) and connected to the ground
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electrode of the power source, was used to collect the aligned fibers [17, 130]. The
rotating collector was placed 7.5 cm below the needle, with the edge of the wheel facing
the needle. The previously optimized electrospinning conditions of 1.0 mL/h injection
rate, 20 kV electrical potential, and needle-to-collector distance of 7.5 cm were used [93].
A rotation speed of 1200 rpm was used to produce aligned PLGA/PLA-GLU fibers,
hereafter denoted by GLU-NF.
3.2.3 CHARACTERIZATION OF GLU-CONJUGATED NANOFIBERS
Scanning electron microscopy (SEM) was used to image the nanofibers. After
coating with gold (Polaron sputter coater, Quorum Technologies, New Haven, UK) at 20
mA for 45 sec, the fiber mesh was attached to a SEM stub and imaged with a Field
Emission Scanning Electron Microscope (FESEM, Carl Zeiss Microscopy, Hillsboro,
OR) at an accelerating voltage of 8 kV. SEM images were analyzed with ImageJ software
(National Institutes of Health, Bethesda, MD) to determine the average fiber size.
To determine surface coverage of GLU peptide on aligned nanofibers, EEGGKC
peptide (GLUK) containing a lysine residue between the glycine and cysteine residues
was synthesized and conjugated to LMW-PLA. After electrospinning, the fibers were
fluorescently labeled with fluorescein isothiocyanate (FITC, Sigma-Aldrich) in 5 mg/mL
Dulbecco’s phosphate-buffered saline (PBS, Cellgro, Herndon, VA) for 4 h at ambient
conditions. FITC, due to its size, reacts only with free lysine amine group of GLUK on
the fiber surface. Therefore, assuming addition of lysine to EEGGC peptide did not
significantly change the peptide surface density, the FITC fluorescent intensity was
related to GLU density on the fiber surface. FITC-labeled GLUK-conjugated nanofibers
were imaged with an inverted fluorescent microscope (Nikon Eclipse Ti-ε, Nikon,

33

Melville, NY). Next, the labeled nanofibers were dissolved in DMSO and fluorescent
intensity was quantified with a Synergy HT plate reader (Bio-Tek, Winooski, VT) at
emission and excitation wavelengths of 520 and 495 nm, respectively. Knowing mass and
average size of the fibers, the intensities were converted into mass per unit surface area
using a calibration curve generated by measuring the fluorescent intensity of solutions
with known concentration of FITC in dimethylsulfoxide (DMSO, Sigma-Aldrich). PLGA
nanofibers without EEGGKC peptide dissolved in DMSO were used as negative control.
3.2.4 CaP NUCLEATION AND GROWTH ON GLU-NF MICROSHEETS
GLU-NF microsheets, approximately 25 µm thick, were incubated in a modified
10-fold concentrated simulated body fluid (m10SBF) [106]. Briefly, the stock solution of
10SBF was prepared by dissolving sodium chloride (NaCl), potassium chloride (KCl),
calcium chloride monohydrate (CaCl2• H2O), magnesium chloride hexahydrate (MgCl2•
6H2O), sodium bicarbonate (NaHCO3), and monosodium phosphate (NaH2PO4), all
purchased from Fisher, in DDI water. The final pH of 10SBF solution was 4.2. Next, 60
mM solution of NaHCO3 was added to 10SBF stock solution to reach physiological pH
of 7.4. Then, the suspension was centrifuged and filtered (220 nm pore-size) prior to
incubation. The modified-10SBF (m10SBF) solution was transparent after filtration,
containing no CaP crystals when incubated with GLU-NF microsheets. During
incubation, the containers were sealed with Parafilm to prevent a change in solution pH
by CO2 diffusion. The incubation solution was changed every 6 h to replenish calcium
and phosphate components. At each time point, fiber sheets were washed with DI water
and dried at ambient conditions.
In the layer-by-layer approach, the first GLU-NF microsheet, approximately 5 µm
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thick, was electrospun on a 12 mm circular glass coverslip (VWR, Bristol, CT). Next, the
microsheet was incubated in m10SBF for the prescribed time, washed with DI, and dried.
After drying, the second GLU-NF layer was electrospun directly on the first layer. The
bilayer sheet was incubated in m10SBF for a prescribed time, washed with DI, and dried.
This layer-by-layer process was repeated five times to produce a 26±2 μm thick
mineralized multilayer GLU-NF circular sheet (12 mm diameter). The multilayer
approach improved diffusion of calcium and phosphate ions inside the fiber sheet when
incubated in m10SBF solution.
The mineralized microsheets were imaged with FESEM as described above. The
calcium to phosphate ratio of the microsheets was measured by an energy-dispersive Xray spectrometer (EDS) connected to FESEM at an accelerating voltage of 15 kV. The
structure of CaP crystals on GLU-NF microsheets was determined by Wide-Angle X-Ray
Diffraction (XRD) using a Philips diffractometer with CuKα radiation source at 30 kV
(Model 405S5, Rigaku, Japan). The scanning range was from 10 to 50o with a step size of
0.05o. The water wettability of GLU-NF microsheets before and after mineralization was
measured with a contact angle goniometer (Model DSA-20E, Kruss, Germany). A 10 l
drop of DI water was applied to the fiber surface, photographed immediately and contact
angle (θ) was calculated from the height (h) and breadth (b) of the drop according to
θ=arctan (2h/b) [131].
The amount of CaP nucleation on the microsheets was measured using a
QuantiChrom calcium assay (Bioassay Systems, Hayward, CA) according to
manufacturer’s instructions. Calcium content of the microsheets (0.3 mg) was dissolved
in 0.4 mL of 1M HCl. Next, 5 μL aliquot of the suspension was added to 200 μL of the
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kit working solution. After 3 min incubation, absorbance was measured on a Synergy HT
plate reader at a wavelength of 612 nm. Measured intensities were correlated to the
equivalent amount of Ca2+ using a calibration curve constructed with reference CaCl2
solutions (zero to 200 μg/mL concentration). Total mineralized deposit of each sample
was determined from the measured calcium contents at each time point (2, 4, 6, 12, and
24 hours) and the CaP ratios from EDS measurements, and divided by the fiber mass to
find percent CaP. Tensile modulus of the samples was measured with a Rheometrics
Dynamic Mechanical Analyzer (RSA III DMA, Piscataway, NJ) with a strain rate of
0.033/s at ambient conditions. Samples were cut to dimensions of 20 x 5 mm and the
maximum allowed strain was set at 160%. Thickness and width of the samples were
measured with a micro-caliper (Mitutoyo, Aurora, IL) and modulus was calculated as the
slope of the linear region of the stress-strain curve.
3.2.5 CELL ISOLATION AND SEEDING
MSCs were isolated from the bone marrow of 6-8 weeks-old male Wistar rats as
described [125, 127, 132]. Cell isolations were performed under a protocol approved by
the Institutional Animal Care and Use Committee of the University of South Carolina.
The marrow was flushed with 20 mL of cell isolation medium which consisted of
Dulbecco’s Modified Eagle’s Medium (DMEM; 4.5 g/L glucose with L-glutamine and
without sodium pyruvate, Cellgro, Herndon, VA) and 10% Fetal bovine serum (FBS,
Atlas Biologicals, Fort Collins, CO) supplemented with 100 units/mL penicillin (PN),
100 μg/mL streptomycin (SP), 20 μg /mL fungizone (FG), and 50 μg /mL gentamicin
sulfate (GS), all purchased from Sigma-Aldrich. The cell suspension was cultured in
basal medium (DMEM supplemented with 10% FBS, 100 units/mL PN, 100 µg/mL SP,
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50 µg/mL GS, and 250 ng/mL FG). Cultures were replaced with fresh medium at 3 and 7
days to remove unattached cells. Cells were enzymatically lifted and used for cell culture
experiments. For cell seeding, edges of the microsheets on 12 mm circular glass coverslip
were coated with a medical-grade silicone sealant (Dow Corning, MI) to prevent
separation of the mesh from coverslip. The construct was sterilized by ultraviolet (UV)
radiation followed by immersion in 70% ethanol for 30 min and washing three times with
sterile PBS. We and others have demonstrated that UV radiation followed by immersion
in ethanol is an effective procedure for sterilizing nanofibers [89, 93, 133]. SEM images
(a) and (b) in Figure 3.7 show the morphology of GLU-NF nanofibers before and after
ethanol incubation and washing steps during sterilization, respectively; images (c) and (d)
show the morphology GLU-NF/CaP50 nanofibers before and after sterilization. The
images in Figure 3.7 indicate that the sterilization procedure had no visible effect on the
alignment or size of the fibers (images a and b) and attachment of CaP deposits to the
fiber surface (images c and d). After conditioning the fiber mesh in basal medium for 1 h,
each sample was seeded with 60 µL MSC cell suspension (1.7x106 cells/mL; 1x105
cells/cm2) in basal medium. After incubation for 24 h for cell attachment, the medium
was replaced with osteogenic medium (basal medium supplemented with 100 nM
dexamethasone, 50 µg/mL ascorbic acid, 10 mM ß-glycerophosphate) and cultured in a
humidified 5% CO2 incubator for up to 28 days. MSCs seeded on GLU-NF/LBL/CaP200
microsheets and incubated in basal medium without osteogenic factors (GLUNF/LBL/CaP200-BM group) were used as the negative control group. To determine cell
viability, MSCs seeded on the microsheets were stained with Acetomethoxy derivative of
calcein (cAM, Life Technologies, Grand Island, NY) and ethidium homodimer (EthD,
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Life Technologies) to image live and dead cells, respectively. Stained samples were
imaged with a Nikon Eclipse Ti-ε inverted fluorescent microscope. Cell viability was
quantified by dividing the image into smaller squares and counting the number of live
and dead cells manually.
3.2.6 OSTEOGENIC DIFFERENTIATION OF MSCs ON CaP-DEPOSITED GLU-NF
MICROSHEETS
At each time point (7, 14, 21, and 28 days), cell-seeded nanofibers were washed
with serum-free DMEM for 8 h to remove serum proteins, followed by washing with
PBS and lysed with 10 mM Tris supplemented with 0.2% triton in PBS. The lysed
samples were used for measurement of DNA content, ALPase activity and calcium
content. Double-stranded DNA content, ALPase activity and calcium content of the
samples were measured with Quant-it PicoGreen assay (Invitrogen), QuantiChrom
ALPase assay (Bioassay Systems) and QuantiChrom Calcium Assay (Bioassay Systems),
respectively, as described [134]. To determine extent of mineralization of the samples,
the measured intensities at time zero, used as baseline, were subtracted from those at days
7-28 to account for the deposited CaP prior to cell seeding. The measured ALPase
activities and calcium contents were normalized to cell numbers by dividing to DNA
contents at each time point.
3.2.7 IMMUNOFLUORESCENT STAINING
For immunofluorescent staining, cell-seeded microsheets were washed twice in
PBS and fixed with 4% paraformaldehyde (Sigma-Aldrich) at 4°C for 12 h. Next,
samples were permeabilized with 0.1% Triton X-100 and 100 mM glycine in PBS for 1 h
and blocked with 1.5% BSA and 0.5 mM glycine in PBS for 2 h. Then, samples were
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incubated with primary antibodies in PBS containing 1% BSA for 24 h at 4°C according
to manufacturer’s instructions. Primary antibodies from Santa Cruz Biotechnology (Santa
Cruz, CA) included mouse anti-rat OP (1:100 dilution), rabbit anti-rat OC (1:100
dilution), and goat anti-rat Pecam-1 (1:50 dilution). After washing with PBS, samples
were incubated with the secondary antibody (1:100 dilution) in blocking buffer for 2 h at
ambient conditions. Secondary antibodies from Santa Cruz Biotechnology included
donkey anti-mouse FITC-conjugated IgG, donkey anti-rabbit Texas-red conjugated IgG,
and donkey anti-goat Texas-red conjugated IgG. It should be noted that each sample was
stained with 4,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) to image the cell
nuclei and one of the antibodies for OC, OP, or Pecam-1. Secondary antibodies without
the primaries were used as negative controls. For observation of cell morphology, cellseeded GLU-NF microsheets were incubated with 0.16 µM Alexa Fluor® 594 phalloidin
(Invitrogen) and 300 nM DAPI for 30 min at ambient conditions to stain the cell actin
filaments and nuclei, respectively. The stained samples were imaged with a Nikon
Eclipse Ti-ε inverted fluorescent microscope to observe cell morphology or expression
pattern of the proteins with the same exposure time and light intensity.
3.2.8 mRNA ANALYSIS OF MSCs ON CaP-DEPOSITED GLU-NF MICROSHEETS
At each time point (7, 14, 21, and 28 days), total cellular RNA was isolated using
TRIzol (Invitrogen) as described [134]. 1µg of the extracted purified RNA was subjected to
cDNA conversion using Promega Reverse Transcription System (Madison, WI). The
obtained cDNA was subjected to real time quantitative polymerase chain reaction (rtqPCR) amplification with appropriate gene specific primers. The expression level of
ribosomal protein S16 was used as the endogenous control. Primers for real-time PCR
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analysis were designed and selected using Primer3 web-based software as described [125,
135]. Real-time PCR (RT-qPCR) was performed to analyze differential expression of OP,
ALPase, OC, Collagen type I (Col-1), Pecam-1 and Flk-1

genes with SYBR green

RealMasterMix (Eppendorf, Hamburg, Germany) using Bio-Rad CXF96 machine (BioRad, Hercules, CA). Forward and reverse primers, shown in Table 1, were synthesized by
Integrated DNA technologies (Coralville, IA). The designed primer sequences
corresponded closely to the previously reported sequences for OP, ALPase, OC, Col-1,
Pecam-1 and Flk-1 genes in rat MSCs [136, 137]. Relative gene expression levels were
quantified by the 2^–ddCT method as described [138, 139]. Relative gene expressions were
expressed as fold difference compared with that at time zero.
Table 1 Forward and reverse sequences of the PCR primers.
Genes
ALPase
Osteocalcin
Osteopontin
Col-I
PECAM-1
Flk-1
S16

Forward Primer
Reverse Primer
5′-CCT TGA AAA ATG CCC TGA AA-3′ 5′-CTT GGA GAG AGC CAC AAA GG-3′
5′-AAA GCC CAG CGA CTC T-3′
5′-CTA AAC GGT GGT GCC ATA GAT-3′
5′-GAC GGC CGA GGT GAT AGC TT-3′ 5′-CAT GGC TGG TCT TCC CGT TGC-3′
5′-TGC CGA TGG CGC TAT C-3′
5′-CAA GGG CCG GGG TGA CGC GGG-3′
5′-CGA AAT CTA GGC CTC AGC AC-3′ 5′-CTT TTT GTC CAC GGT CAC CT-3′
5′-TAG CGG GAT GAA ATC TTT GG -3′ 5′-GGG GTG AGG ATG ACC GTG TA-3′
5′-AGT CTT CGG ACG CAA GAA AA-3′ 5′-AGC CAC CAG AGC TTT TGA GA-3′

3.2.9 STATISTICAL ANALYSIS
Data are expressed as means±standard deviation. All experiments were done in
triplicate. Significant differences between groups were evaluated using a two-tailed
Student's t-test. A value of p<0.05 was considered statistically significant.
3.3 SIMULATION METHOD
Dissipative Particle Dynamics (DPD) method was used to simulate surface and
bulk distribution of PLGA and PLA-GLU in the nanofibers by course-graining the
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macromers into different set of atoms or beads as described [140, 141]. Bead types
included lactide, glycolide, acrylate, amino acid backbone chain, cysteine side group, and
glutamic acid side group. The position and velocity of the beads at each time point were
determined by solving equations of motion of the beads using the DPD force function.
The force acting on each bead ( f i ) is given by [142, 143]

f ij   FijC  FijD  FijR  FijS
i j

(1)
FijC , FijD , FijR and FijS are the conservative, dissipative, random and spring

where

components of the force, respectively. FijD , FijR and FijS were calculated as described [140,
141]. The interaction force FijC between non-bonded beads is given by [143]
αij ( 1  rij ) eij
FijC  
0

rij  1
rij  1

(2)
where

rij

is the vector joining bead i to j, eij and rij are the unit vector in the direction of

rij and the magnitude of rij in DPD units, respectively. DPD length scale rc was 7.87 Ǻ

and the values of αij were determined from the Flory-Huggins interaction parameters (  ij
) as described [140, 144]. The Flory−Huggins parameters were calculated via atomistic
molecular dynamics simulation (Forcite and Amorphous Cell modules, Materials Studio
v5.5, Accelrys) using COMPASS, which is an ab initio force field optimized for
condensed-phase systems [145]. The randomly seeded macromers in a cylindrical
template were simulated with dimensionless time step of 0.05 and over 200000 time
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steps.

The repulsive boundary condition applied on the fiber surface to maintain

cylindrical geometry was equal for all beads, which did not affect bead distribution. DPD
simulations were performed using Mesocite module (Materials Studio v5.5).
3.4. RESULTS
3.4.1 CHARACTERIZATION OF CaP-DEPOSITED GLU-NF MICROSHEETS
GLU peptide was covalently attached to Ac-PLA by the reaction between the
acrylate group of Ac-PLA and cysteine residue of the peptide, as shown in Figure 3.1a.
1

H-NMR spectrum of Ac-PLA (inset) and PLA-GLU are shown in Figure 3.1b. Chemical

shifts with peak positions at 2.14, 2.32 and 4.57 were attributed to methylene and methine
hydrogens of glutamate residues; that at 4.16 was attributed to methylene hydrogens of
glycine residues; those at 5.19 and 8.03 were attributed to amine and amide hydrogens,
respectively; and those at 3.11 and 3.77 were attributed to methylene and methine
hydrogens of cysteine residue, respectively. Chemical shifts with peak positions at 1.78
and 5.35 ppm were attributed to methyl and methine hydrogens of lactide units,
respectively; that at 3.64 ppm was attributed to methylene hydrogens of DEG in Ac-PLA.
Chemical shifts with peak positions in the 6.04-6.48 ppm range were attributed to vinyl
hydrogens of the acrylate end groups of Ac-PLA. Ratio of the peaks at 6.04-6.48 ppm
(due to hydrogens of acrylate) to that at 5.35 ppm (due to hydrogens of lactide) was
related to acrylate/LA molar ratio in Ac-PLA macromer. Number of peptides in the
conjugate was determined using the acrylate/LA molar ratio before and after conjugation.
Average number of peptides per conjugate was 1.3.
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Figure 3.1 (a) Reaction scheme for synthesis of PLA-CGGEE (PLA-GLU) conjugate. (b)
1
H-NMR spectrum of PLA-GLU macromer; the inset in (b) is NMR spectrum of AcPLA. NMR peaks labeled with LA, AA, and Ac represent lactide, amino acid, and
acrylate peaks, respectively.
Concentration of PLA-GLU in the fibers ranged from zero to 2.5 mM. Average
size of the aligned fibers was 200 ±60 nm. Image of PLGA/PLA-GLUK fibers, shown in
Figure 3.2a, showed intense fluorescent emission from FITC conjugation to the fiber
surface. FITC-labeled fibers were dissolved in DMSO and fluorescent intensity was
quantified and related to GLU peptide concentration, as shown in Figure 3.2b. GLU
density on the fiber surface increased linearly with PLA-GLU concentration up to 2 mM,
followed by a slight, statistically not significant increase for higher concentrations. As
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PLA-GLU concentration was increased from 0.6 mM to 1.2, 2.0, 2.3 and 2.5 mM, GLU
surface density increased from 5.4±1.2 to 12.3±0.9, 20.3±2.5, 20.7±2.7, and 21.1±2.3
nmol/cm2, respectively. DPD simulation of PLGA/PLA-GLU nanofibers to predict GLU
distribution on the fiber surface in a 30 x 20 x 20 rc simulation box without HFIP
electrospinning solvent is shown in Figure 3.2c. In the figure, beads other than GLU (red
color) are shown with grey color for clarity. The percentage of GLU groups on the fiber
surface without and with 5% HFIP solvent was 82% and 83%, respectively, and the
average number of GLU peptides on the surface was 0.16 GLU/nm2.

Figure 3.2 (a) Fluorescent image of FITC conjugated PLA-GLUK nanofibers with 20
nmol/cm2 GLUK peptide surface density. (b) Effect of PLA-GLUK peptide concentration
in the electrospinning solution on GLUK peptide surface density on aligned nanofibers.
(c) DPD simulation of PLGA/PLA-GLU showing localization of GLU groups (red) on
the surface of nanofibers (grey) within the simulation box. Error bars in (a) and (b)
correspond to mean ±1 SD for n = 3.

The schematic diagram of apatite deposition on 2-mer Glutamic acid peptide
conjugated nanofibers in simulated body fluid is represented in Figure 3.3. Typical low
magnification images of nanofibers (without GLU conjugation) and GLU-NF after
incubation in m10SBF for 24 h are shown in Figures 3.4a and 3.4b, respectively. Figures
3.4c-f show higher magnification images of GLU-NF after incubation in m10SBF for 6,
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24, 48 h, and LBL 24 h, respectively. CaP crystals nucleated from the fiber surface after 6
h incubation can be seen in Figure 3.4c. As incubation time increased to 24 and 48 h,
number of CaP crystals increased significantly, as shown in Figures 3.4d and 3.4e,
respectively. Figure 3f shows uniform distribution of CaP crystals on fibers within as
well as on the surface of microsheets. However, average size of the crystals did not
change with incubation time and remained below 100 nm. The schematic diagram of
apatite deposited GLU-NF fabrication by layer-by-layer approach can be seen in Figure
3.5a. In addition, Figure 3.5b and 3.5c shows the low and high magnification image of 5
layers apatite/GLU-NF cross-section, respectively. The average thickness of CaP
nucleated 5 layers GLU-NF is 25±1 µm.

Figure 3.3 The schematic diagram of apatite deposition on 2-mer Glutamic acid peptide
conjugated nanofibers in simulated body fluid.

The effect of GLU conjugation and CaP deposition on water wettability of the
microsheets is shown in Figure 4a-c. Water contact angel decreased to 85±3º (Figure
3.6b) from 112±3º (Figure 3.6a) after blending PLGA with PLA-GLU. The mineralized
microsheets were completely wetted by water (zero contact angle, Figure 3.6c). The
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measured contact angles were consistent with previously reported values for PCL
modified with carboxylic acid groups [146, 147]. The amount of CaP crystals (based on
fiber mass) deposited on NF (burgundy), GLU-NF (blue), and GLU-NF/LBL (brown)
microsheets with incubation time is shown in Figure 3.6d. As incubation time increased
from 2 to 4, 6, 12, and 24 h, amount of CaP deposited on NF microsheets changed from
2.8±2.2% to 8.7±0.9, 8.6±2.5, 11.6 ±1.0, and 12.1±2.5%, respectively, while the amount
deposited on GLU-NF microsheets increased from 13.3±0.7% to 28.0±3.8, 29.4±4.5,
37.0±5.1, and 50.0±5.6%. Amount of CaP deposited on NF microsheets did not increase
significantly with incubation time while CaP deposition on GLU-NF sheets increased
significantly (indicated by one star). Interestingly, amount of CaP deposited with the LBL
approach (24 h incubation in each layer) increased to 203±5% compared to 50.0±5.6%
for a single 25 µm layer. These results indicated that the GLU peptide provides sites for
nucleation of CaP crystals [148] and CaP deposition is limited by the diffusion of
calcium/phosphate ions to the interior part of GLU-NF microsheets.
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Figure 3.4 SEM images of the microsheets after incubation in m10SBF medium. Images
(a) and (b) are low magnification images of PLGA and PLGA/PLA-GLU microsheets
after incubation in m10SBF for 24 h, respectively. Images (c), (d), and (e) are for
PLGA/PLA-GLU microsheets after 6, 24, and 48 h incubation in m10SBF, respectively.
Image (f) is for PLGA/PLA-GLU microsheets deposited with CaP crystals in a layer-bylayer (LBL) approach. Scale bars in (a-b) and (c-f) represent 2 µm and 200 nm,
respectively.
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Figure 3.5. Schematic diagram of apatite deposited GLU-NF fabrication by layer-bylayer approach (a), low magnification image of 5 layers apatite/GLU-NF cross-section
(b), high magnification image of 5 layers apatite/GLU-NF cross-section.
Tensile modulus and toughness of GLU-NF microsheets are given in Figures 3.6e
and 3.6f, respectively. Tensile modulus increased significantly with extent of CaP
deposition on the fibers, especially in the LBL approach. Tensile modulus increased from
260±10 MPa for GLU-NF to 330±17, 540±15, and 880±40 MPa for GLU-NF with 30%
(6 h incubation), 50% (24 h incubation), and 200% (LBL) CaP deposition. There was a
sharp increase in toughness when CaP deposition was increased to 50% and 200%,
indicating overlap/fusion of crystals on the fibers and formation of a CaP-NF network.
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Figure 3.6 Shape of a water droplet on PLGA NF (a), PLGA/PLA-GLU NF before (b)
and after incubation in m10SBF (c). All PLGA/PLA-GLU NF microsheets had zero
water contact angle after incubation in m10SBF, irrespective of incubation time. The
contact angles in (a), (b), and (c) were 112±3º, 85±3º, and zero, respectively. (d) Amount
of CaP nucleation and growth (based on fiber mass) on PLGA fibers without GLU
conjugation (NF, burgundy, 25 µm thick layer) and PLGA/PLA-GLU fibers (GLU-NF,
blue, 25 µm thick layer) with incubation time in m10SBF. (e) and (f) are tensile modulus
and toughness of PLGA/PLA-GLU fibers as a function of CaP amount deposited on the
fibers, respectively. The brown bar in (d-f) is for PLGA/PLA-GLU microsheets produced
in a 5-layer LBL approach (each layer 5 µm thick) incubated in m10SBF for 24 h. (g)
Comparison of x-ray diffraction spectra of CaP crystals deposited on PLGA NF (NF/CaP,
blue) and CaP crystals deposited on PLGA/PLA-GLU microsheets (GLU-NF/CaP50,
green) after 24 h incubation in m10SBF with that of commercial HA nanocrystals (nHA,
orange). Peaks centered at 25.8°, 31.8°, and 47° are characteristic diffraction peaks of
apatite crystals. (h) EDS spectrum of CaP crystals nucleated and grown on GLUNF/CaP50 fibers (Ca:P =1.58). In (d-f), one star indicates statistically significant
difference (s.d.; p<0.05) between the test group and control [NF in (d) and GLUNF/CaP0 in (e) and (f)]; two stars between multilayer and monolayer GLU-NF/CaP.
Error bars in (d-f) correspond to means ± 1 SD for n = 3.

The mechanical measurements are consistent with previous results for CaP-deposited
PCL NFs, surface modified with carboxylic acid groups [149]. XRD spectra of NF (blue)
and GLU-NF (green) microsheets after 24 h incubation in m10SBF are compared in
Figure 4g with that of synthetic apatite nanocrystals (red, Berkeley Biomaterials,
Berkeley, CA). CaP crystals deposited on GLU-NF microsheets showed the characteristic
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apatite peaks centered at 31.8o, 25.8o, and 47o [150] while NF sheets without GLU did not
show those peaks. Ca/P ratio of the crystals was 1.58±0.1, based on the EDS spectrum of
GLU-NF microsheets after 24 h incubation in m10SBF in Figure 4h, which was in the
reported range of 1.4-1.7 for CaP crystals in the natural bone and close to 1.67 for
synthetic apatite crystals [116]. Similar results were obtained for GLU-NF microsheets
incubated in m10SBF for different times.
3.4.2 DIFFERENTIATION OF MSCs ON CaP-DEPOSITED GLU-NF MICROSHEETS
MSCs were seeded on GLU-NF, GLU-NF with 30% (GLU-NF/CaP30), 50% (GLUNF/CaP50), and 200% (GLU-NF/LBL/CaP200) CaP content, and cultured in osteogenic
medium for 28 days. MSCs seeded on GLU-NF/LBL/CaP200 with highest CaP content
of 200% and incubated in basal medium was used as the negative control group (GLUNG/LBL/CaP200-BM) for biochemical, mRNA and immunocytochemical analysis. To
observe the morphology of individual cells, MSCs were seeded on the microsheets at low
density of 1500 cells/cm2 and incubated in osteogenic medium. Fluorescent images (a-d)
of cell nuclei (blue) and cytoskeletal actin filaments (red) in Figure 3.9 show morphology
of the MSCs seeded on GLU-NF (a), GLU-NF/CaP30 (b), GLU-NF/CaP50 (c), and
GLU-NF/LBL/CaP200 (d) microsheets after two days of incubation. The images indicate
that the seeded cells completely aligned with fiber direction even after CaP deposition.
Inset images in Figure 3.9 show the corresponding morphology of MSCs with initial
seeding density of 1x105 cells/cm2 after 7 days of incubation in osteogenic medium. The
seeded MSCs displayed an elongated morphology in the direction of the fibers for all CaP
contents at higher density and longer incubation time. Images of live (green, cAM
stained) and dead (red, EthD stained) MSCs two days after cell seeding at high density on
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the microsheets, displayed in Supplementary Figure 3.8, showed >90% cell viability two
days after cell seeding (1x105 cells/cm2) and incubation in osteogenic medium.

Figure 3.7 SEM images of the microsheets after sterilization with by ultraviolet (UV)
radiation followed by immersion in 70% ethanol for 30 min and washing three times with
sterile PBS. Images (a) and (b) are PLGA/PLA-GLU microsheets before sterilization and
after sterilization procedure. Images (c) and (d) are for PLGA/PLA-GLU microsheets
after 24hincubation in m10SBF before sterilization and after sterilization, respectively.
Scale bars in (a-b) and (c-f) represent 2 µm and 2 µm, respectively.
DNA content of MSCs cultured on GLU-NF/CaP microsheets is shown in Figure
3.10a. DNA content of GLU-NF/LBL/CaP200-BM (light blue) incubated in basal
medium, in the absence of osteogenic differentiation factors, increased slightly with
incubation time while those incubated in osteogenic medium decreased significantly with
time. The cell density for CaP deposited microsheets on day 7 was significantly higher
than that of GLU-NF, as indicated by a star in Figure 3.10a, consistent with previous
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results for cell adhesion on mineralized nanofibers [116]. Cell number results suggested
that the CaP deposited microsheets did not have a toxic effect on the seeded cells and the
decrease in DNA content of MSC-seeded microsheets incubated in osteogenic medium
was related to cell differentiation or the initial seeding density (see Discussion).

Figure 3.8 Live (green) and dead (red) image of MSCs (1500 cells/cm2 initial density)
seeded on GLU-NF (a), GLU-NF/CaP30 (b), GLU-NF/CaP50 (c), and GLUNF/LBL/CaP200 (d) microsheets after two days of incubation in osteogenic medium
(scale bar is 100 µm).
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Figure 3.9 Morphology of MSCs (1500 cells/cm2 initial density) seeded on GLU-NF (a),
GLU-NF/CaP30 (b), GLU-NF/CaP50 (c), and GLU-NF/LBL/CaP200 (d) microsheets
after two days of incubation in osteogenic medium (scale bar is 50 µm). The inset in each
image shows the corresponding image of MSCs seeded on GLU-NF microsheets at 1x105
cells/cm2 density after 7 days of incubation in osteogenic medium (scale bar in the insets
is 100 µm). In the images, cell nuclei and cytoskeletal actin are stained with DAPI (blue)
and phalloidin (red), respectively. The arrow in the images shows direction of the aligned
nanofibers.
ALPase activity of MSCs seeded on GLU-NF/CaP microsheets is shown in
Figure 3.10b. ALPase activity of MSCs seeded on GLU-NF/LBL/CaP200-BM
microsheets incubated in basal medium did not increase with time (light blue curve).
ALPase activity of all other groups, incubated in osteogenic medium, peaked after 14
days and returned to baseline level at day 28, consistent with previous reports [151].
ALPase activity increased significantly with amount of CaP deposition on the fibers. For
example, peak ALPase activity of GLU-NF/CaP30, GLU-NF/CaP50, and GLUNF/LBL/CaP200 increased from 2400±200 to 3200±600 and 5100±400 IU/mg DNA,
respectively, while that of GLU-NF was 1600±100 IU/mg. Mavis and collaborators
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reported that MC3T3-E1 pre-osteoblasts seeded on apatite-coated PCL fibers had higher
ALPase activity compared to uncoated fibers [123]. Calcium content of MSCs seeded on
CaP-deposited microsheets is shown in Figure 3.10c. All calcium measurements were
subtracted from the amount at day 4 to remove the calcium due to CaP deposition prior to
cell seeding. For all groups, extent of mineralization of the MSCs increased gradually
from day 14 to 28 with GLU-NF/LBL/CaP200 having the highest mineralization after 28
days of incubation in osteogenic medium. Mineral content of the MSCs seeded on GLUNF/LBL/CaP200-BM incubated in basal medium increased slightly with time, which
could be related to the osteogenic effect of deposited CaP prior to cell seeding. For
example, calcium content of MSC-seeded GLU-NF/LBL/CaP200 microsheets after 28
days was 960±110 mg/mg DNA, while those of GLU-NF/LBL/CaP200-BM, GLU-NF,
GLU-NF/CaP30, and GLU-NF/CaP50 were 130±20, 460±40, 580±40, and 760±80
mg/mg DNA, respectively.
Expression of osteogenic markers OP, ALPase, OC, Col-1, and vasculogenic
markers Pecam-1 and Flk-1 with incubation time for MSC-seeded GLU-NF/CaP
microsheets is shown in Figures 3.11a through 3.11f, respectively. For GLUNF/LBL/CaP200-BM control group incubated in basal medium, expression of OP,
ALPase, OC, Pecam-1, and Flk-1 did not change significantly with time, while there was
a significant increase in Col-1 expression. However, the increase was significantly less
than those microsheets incubated in osteogenic medium (see Figure 3.11d). ALPase
mRNA expressions for all groups followed their corresponding ALPase activity shown in
Figure 3.10b, peaking at day 14 and returning to baseline level at day 28 [152]. mRNA
expression of OP, OC, and Col-1 increased gradually with incubation time. Expression of
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osteogenic marker OP was was highest for GLU-NF/LBL/CaP200, as shown in Figure
3.11a. For example, OP expression of GLU-NF/LBL/CaP200 at day 28 was 68±4 while
those of GLU-NF, GLU-NF/CaP30, and GLU-NF/CaP50 was 16±2 and 25±3, 48±3,
respectively. Expression of osteogenic markers OC and Col-1 followed a similar trend
with GLU-NF/LBL/CaP200 having the highest expression (420±30). For example, OC
expression of GLU-NF, GLU-NF/CaP30, GLU-NF/CaP50, and GLU-NF/LBL/CaP200 at
day 28 was 180±10, 250±30, 300±20, and 420±30, respectively, while that of Col-1 was
6±1, 11±2, 14±1, and 16±1. Expression of Pecam-1 and Flk-1 of the MSCs did not
change significantly with incubation time and CaP deposition, which indicated that CaP
deposition on the fibers mainly affected osteogenic expression. Pecam-1 and Flk-1
expression for GLU-NF/LBL/CaP200 was slightly higher than the other groups at day 28
(see Figures 3.11e and 3.11f).
Figure 3.12 shows immunostained images of MSCs seeded on GLU-NF/CaP
microsheets. Columns a through c in Figure 3.12 are for OC (red), OP (green), and
Pecam-1 (red), respectively, and rows 1-5 are for GLU-NF/LBL/CaP200-BM incubated
in basal medium as negative control, GLU-NF, GLU-NF/CaP30, GLU-NF/CaP50 and
GLU-NF/LBL/CaP200 after 28 days of incubation in osteogenic medium. GLUNF/LBL/CaP200-BM did not stain for OC, OP, or Pecam-1 markers (see first row).
GLU-NF group showed weak staining for all three markers while the CaP deposited
GLU-NF groups showed moderate to strong staining for osteogenic markers OC and OP.
There was a slight increase in Pecam-1 staining for GLU-NF/LBL/CaP200 group,
consistent with the slight increase in mRNA expression in Figure 3.11e. Overall, GLUNF/LBL/CaP200 group showed highest staining for OC, OP, and Pecam-1. Taken
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together, results in Figures 3.10-3.12 demonstrate that the extent of osteogenic
differentiation of MSCs seeded on GLU-NF microsheets depended strongly on the
amount of deposited CaP on the fibers prior to cell seeding.

Figure 3.10 DNA content (a), ALPase activity (b), and calcium content (c) of MSCs
seeded on GLU-NF/CaP microsheets and incubated in osteogenic medium for up to 28
days. Experimental groups include GLU-NF without incubation in m10SBF (control,
blue), GLU-NF/CaP30 (red), GLU-NF/CaP50 (green), and GLU-NF/LBL/CaP200
(purple) incubated in osteogenic medium. GLU-NF/LBL/CaP200-BM group was
incubated in basal medium as the negative control (light blue). In the figures, one star
indicates statistically significant difference (s.d.; p<0.05) between the test group and
GLU-NF for the same time point; two stars between the test time point and the previous
time in the same group; three stars between GLU-NF/LBL/CaP200 and other GLUNF/CaP groups for the same time point. Error bars correspond to means ± 1 SD for n = 3.
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Figure 3.11 mRNA expression levels (as fold difference) of osteopontin (a, OP), alkaline
phosphatase (b, ALPase), osteocalcin (c, OC), collagen type-1 (d, Col-1), platelet
endothelial cell adhesion molecule (e, Pecam-1), and Flk-1 (f) for MSCs seeded on GLUNF/CaP microsheets and incubated in osteogenic medium for up to 28 days.
Experimental groups include GLU-NF without incubation in m10SBF (blue), GLUNF/CaP30 (red), GLU-NF/CaP50 (green), and GLU-NF/LBL/CaP200 (purple). GLUNF/LBL/CaP200-BM group was incubated in basal medium as the negative control (light
blue). In the figures, one star indicates statistically significant difference (s.d.; p<0.05)
between the test group and GLU-NF for the same time point; two stars between the test
time point and the previous time in the same group; three stars between GLUNF/LBL/CaP200 and other GLU-NF/CaP groups for the same time point. Error bars
correspond to means ± 1 SD for n = 3.
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Figure 3.12 Expression pattern of osteogenic markers osteocalcin (a, OC, red, first
column), osteopontin (b, OP, green, second column), and vasculogenic marker Pecam-1
(c, red, third column) for MSCs seeded on GLU-NF/CaP microsheets after 28 days
incubation in osteogenic medium. Experimental groups include GLU-NF without
incubation in m10SBF (control), GLU-NF/CaP30, GLU-NF/CaP50, and GLUNF/LBL/CaP200. Expression pattern of MSCs in GLU-NF/LBL/CaP200-BM negative
control group, which was incubated in basal medium, is shown in the first row. Cell
nuclei in the images are stained with DAPI (blue).
3.5 DISCUSSION
The simulated percentage of GLU groups on the fiber surface was >80%.
Although diameter of the simulated fibers was significantly less than the actual fiber
diameter, simulation results indicated that a major fraction of GLU peptides localized to
the fiber surface. Consistent with simulation results, Gentsch and collaborators
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functionalized PLGA electrospun nanofibers by blending with poly(lactic acid)-blockCGGRGDS conjugate and reported a decrease in water contact angle on the fiber surface
with increasing concentration of

the conjugate [153]. It should be noted that the

simulations were performed in the absence of electric field, thus the actual GLU
percentages on the fiber surface may be higher than the predicted values. Sun and
collaborators used the electric field applied during electrospinning to induce segregation
of peptides to the fiber surface with poly(ethylene oxide)-peptide conjugates [154]. The
simulation results taken together with contact angle measurements in Figure 3.6a and
fluorescence measurements of FITC labeled PLA-GLUK fibers in Figure 3.2b provide
evidence for localization of a significant fraction of PLA-GLU to the fiber surface when
blended with PLGA, to serve as nucleating sites for CaP deposition.

Figure 3.13 The effect of initial seeding densities of 3x103 (a) and 2.5x104 cells/cm2 (b)
on the microsheets on DNA content with incubation time in osteogenic medium.
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Conjugation of GLU sequence reduced water contact angle on the fiber surface,
as shown in Figure 3.6a-c, with zero contact angle after CaP deposition on the fibers. The
finite water contact angle of <90° on GLU-NF fibers allowed nucleation and growth of
CaP crystals on layers near the fiber surface but it limited penetration of water, calcium,
and phosphate ions inside the microsheets. Consequently, when incubation time of GLUNF microsheets in m10SBF was increased from 24 to 48 h, there was little change in CaP
content and tensile modulus (data not shown). When the LBL approach was used to
produce CaP-deposited microsheets, there was a dramatic increase in CaP content from
50±6 to 200±5%, as shown in Figure 3.6d, indicating that CaP nucleation and growth on
GLU-NF fibers was controlled by diffusion of calcium/phosphate ions from the medium
to inside the microsheets. It should be noted that the CaP content of LBL microsheets was
between those of cancellous (160%) and cortical (310%) bone [155, 156] demonstrating
that CaP contents as high as that of cortical bone can be achieved by reducing layer
thickness. The LBL approach has been used to increase filler loading and stiffness of
composites or fabricate highly ductile oppositely charged multilayered films [157, 158].
Li and collaborators observed increased CaP deposition on PCL microfibers by
increasing the density of carboxylic acid groups on the surface by plasma treatment
[159]. They also observed that CaP deposition increased by coating the surface of PCL
microfibers with gelatin, presumably due to the carboxylic acid content of gelatin [87].
Our work demonstrates for the first time that the extent of CaP nucleation and growth on
synthetic fibers, and in turn the fiber mechanical strength, can be controlled by incubation
time in SBF or by GLU density on the fiber surface.
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The tensile modulus and toughness of the microsheets dramatically increased with
higher CaP contents of 50 and 200%, as shown in Figures 3.6e and 3.6f, respectively.
Zhang et al. reported a decrease in tensile strength and elastic modulus of chitosan
composite microfibers with the addition of HA nanocrystals (nHA) and collagen to the
electrospinning solution [89]. Our results indicate that fiber size, CaP crystal size, and
nucleation and growth of CaP crystals on the fiber surface contribute to the higher
modulus and toughness of the microsheets. The GLU peptide initiateed nucleation of CaP
crystals on the fiber surface. The nucleated CaP crystals continue to grow with incubation
time and start to merge and fuse to form a network of fibers cross-linked with CaP
crystals. We speculate that the higher toughness and modulus of microsheets with 50 and
200% CaP content is related to the formation of CaP cross-linked network of fibers.
DNA content of the MSCs seeded on GLU-NF/LBL/CaP200 microsheets
incubated in osteogenic medium decreased significantly with time, as shown in Figure
3.10a. However, the slight increase in DNA content of MSCs on GLU-NF/LBL/CaP200
microsheets incubated in basal medium (light blue in Figure 3.10a) indicated that the
microsheets did not have toxic effect on the seeded cells. We speculated that the decrease
in cell number with incubation time in osteogenic medium was related to cell
differentiation as well as the initial cell seeding density. The effect of initial seeding
densities of 3x103 and 2.5x104 cells/cm2 on the microsheets on DNA content with
incubation time in osteogenic medium is shown in Figures 3.13a and 3.13b, respectively.
At relatively low initial density of 3000 cells/cm2 (Figure 3.13a), DNA content of the
MSCs on the microsheets increased significantly for all time points in osteogenic medium
and DNA content was relatively independent of the extent of CaP deposition prior to cell
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seeding. As the initial cell density was increased to 2.5x104 cells/cm2 (Figure 3.13b),
DNA content increased in the first 7 days and then remained relatively constant (or
increased slightly) for times between 7 and 28 days as the cells differentiated in
osteogenic medium. With further increase in initial cell density to 1x105 cells/cm2 (Figure
6a), DNA content of the MSCs on the microsheets decreased significantly for all time
points with incubation in osteogenic medium, but remained relatively unchanged in basal
medium (light blue curve in Figure 3.10a). Images of live and dead MSCs two days after
cell seeding on the microsheets, displayed in Figure 3.8, show >90% cell viability two
days after seeding in osteogenic medium, implying that the microsheets did not have a
significant toxic effect on the seeded cells. The other possible reason for the decrease on
DNA content might be the increasing cell surface area after cell adhesion and spread on
the apatite nucleated aligned nanofibers. Figure 9 clearly shows that cells were
completely spread along the fibers even after 7 days of culture in osteogenic media. The
required surface area for proliferated cells adhesion is limited after cells completely cover
the surface of the aligned nanofibers. Therefore, the proliferation slows down and the
death of unattached cells becomes dominant due to the limited surface area. Taken
together, these results demonstrate that the change in DNA content of the MSCs seeded
on the microsheets with incubation time depended on the initial cell seeding density,
culture medium (osteogenic versus basal medium) and increase on the cell surface area
after spreading on the fibers. Kim et al. investigated the effect of initial cell seeding
density on poly(propylene fumarate) substrates on osteogenic expression of rat MSCs
[160]. They reported higher level of mineralization and osteocalcin expression at higher
cell densities of 7.5x104 and 1.5x105 cells/cm2. Zhou et al. investigated osteogenic
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differentiation of umbilical cord stem cells on fiber-reinforced calcium phosphate
scaffolds [161]. They reported increased osteogenic differentiation and mineral
deposition on the scaffolds with increasing cell density from 1.5x104 to 1x105 cells/cm2.
It appears that cell-cell contact plays a significant role in osteogenic differentiation of
MSCs and other stem cells. Based on previous results, a relatively high seeding density of
1x105 cells/cm2 was used to investigate osteognic differentiation of rat MSCs on GLUNF microsheets.
Biochemical, mRNA, and immunocytochemical results show that the extent of
osteogenic differentiation and maturation of MSCs seeded on the microsheets increased
with CaP deposition. This increase can be explained by the higher modulus as well as
higher CaP content of GLU-NF microsheets prior to cell seeding.
These findings are consistent with prior results that matrix stiffness directs stem
cell differentiation [162] and CaP content of the substrate affects osteogenesis [163].
Chaterjee et al. reported that ALPase activity and extent of mineralization of osteoblasts
encapsulated in a polyethylene glycol hydrogel was modulated by matrix stiffness with
400-fold increase in mineralized volume fraction as the matrix stiffness increased by 30
fold [164]. Engler et al. demonstrated that MSCs seeded on stiffest gel matrices (34 kPa
elastic modulus) showed 4-fold greater osteocalcin and the early transcriptional factor
CBFa1 expression [165]. Lee et al. and Chen et al. observed an increase in ALPase
activity and extent of mineralization of MSCs seeded on PCL/nHA nanofibers with HA
content [116, 166]. Similarly, a significant increase in ALPase activity with HA addition
was reported for MC3T3-E1 preosteoblasts seeded on PCL or PLLA fibers [88, 123,
167]. Zhang et al. on the other hand did not observe an increase in osteogenic
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differentiation of human fetal osteoblasts seeded on chitosan fibers with HA addition to
the electrospinning solution [89]. Our results show that osteogenic differentiation of
MSCs depends directly on the extent of CaP deposition on the nanofibers prior to cell
seeding. The extent of osteogenic differentiation of MSCs may also depend on the
connectivity of crystals with increasing CaP deposition. Bhumiratana et al. investigated
nucleation and growth of mineralized matrix on silk-hydroxyapatite (HA) composite
scaffolds seeded with human MSCs [168]. He reported that the initial HA content and its
distribution acted as nucleation sites for new mineral formation, which in turn affected
the connectivity of mineral deposition by MSCs. Although the effect of substrate
modulus and CaP content on differentiation and mineralization MSCs has been studied
extensively, there has been very few reports on the effect of CaP connectivity on the
extent of mineralization by MSCs.
The findings of this work demonstrate that GLU conjugation coupled with an
LBL approach dramatically increase nucleation and growth of apatite-like nanocrystals
on the surface of nanofibers, leading to CaP to fiber ratios >200%, tensile moduli close to
1 GPa, and higher osteogenic differentiation of MSCs. CaP content of the nanofibers can
be further increased to reach that of cortical bone by reducing the thickness of individual
fiber layers in the LBL approach or by reducing porosity of the fiber sheets. The CaP
deposited GLU-NF composites are potentially useful as a biomimetic matrix in
regeneration of skeletal tissues.
3.6 CONCLUSION
In this work, the effect of calcium phosphate (CaP) deposition on aligned
nanofibers surface-modified with EEGGC glutamic acid peptide on osteogenic
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differentiation of rat marrow stromal cells was investigated. In an effort to increase CaP
to fiber ratio, a layer-by-layer approach was used to improve the diffusion of calcium and
phosphate ions inside the microsheets. Based on Dissipative Particle Dynamics
simulation of PLGA/PLA-GLU fibers, >80% of GLU peptide was localized to the fiber
surface. X-ray diffraction results showed the characteristic apatite peaks in CaP crystals
grown on GLU-NF microsheets. CaP to fiber ratio of the microsheets increased from
50% for a single fiber layer to 200% for the LBL microsheet with the same overall
thickness when incubated in a modified SBF medium. Tensile modulus increased from
550 MPa for a single fiber layer to 880 MPa for the LBL microsheet. MSCs seeded on
GLU-NF microsheets after CaP deposition spread along the direction of fiber alignment,
irrespective of the extent of CaP deposition. Osteogenic differentiation of MSCs seeded
on GLU-NF microsheets increased significantly with CaP deposition on the fibers prior
to cell seeding. For example, peak ALPase activity increased from 1600 IU/mg DNA for
GLU-NF without CaP deposition to 5200 IU/mg DNA for CaP-deposited LBL
microsheet, and calcium content after 28 days increased from 460 to 960 mg/mg DNA.
Expression of osteogenic markers OP, ALPase, OC, and Col-1 increased gradually with
increasing CaP deposition on GLU-NF microsheets. The findings of this work
demonstrate that surface modification of nanofibers with GLU peptide by blending
PLGA with PLA-GLU dramatically affects nucleation and growth of calcium phosphate
crystals leading to increased osteogenic differentiation of MSCs and mineralization.
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CHAPTER 4
OSTEOGENIC DIFFERENTIATION OF MARROW STROMAL CELLS IN OSTEONMIMETIC MINERALIZED NANOFIBROUS MICROTUBES
4.1 INTRODUCTION
Cranial, maxillofacial, oral fractures and large bone defects are currently being
treated by using auto- and allografts. These techniques have limitations in the clinical
usage such as immune response, donor-site morbidity, and lack of availability [1, 3, 169].
Therefore, the interest on tissue engineering applications for bone graft procedures has
rapidly been growing. Tissue engineering approach requires a cell supporting scaffold in
order to maintain a 3- dimensional substrate for cells to function during the formation of
bone tissue [5, 6]. Electrospinning has been widely used to fabricate nanofibrous matrices
to mimic the morphology of the collagen fibers in the bone extracellular matrix [16, 170].
Since electrospun nanofibers provide a large surface-to-volume ratio and mimic the
natural extracellular matrix of bone tissue, it has been found to be a suitable scaffold for
bone tissue engineering [18, 19]. Nanofibers has been fabricated from natural
biopolymers, like collagen and chitosan, or synthetic polymers such as poly(L-lactide)
(PLLA) and poly(ε-caprolactone) (PCL)[78, 87-89]. Due to the low mechanical
properties of NFs, composite nanfibrous scaffolds with calcium-phosphate(CaP) crystals
can provide adequate mechanical properties and support for cell attachment, proliferation,
and differentiation of mesenchymal stem cells[116, 171]. Nucleation of CaP nanocrystals
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on collagen fibers in the bone matrix is mediated by ECM non-collagenous proteins such
as bone sialoprotein (BSP), osteonectin (ON), osteopontin (OP), and osteocalcin
(OC).[124, 172, 173] Glutamic acid (GLU) sequences ranging from 2-10 residues in
those proteins regulate nucleation and growth of CaP crystals on collagen fibers [124].
Therefore, 2mer GLU was conjugated on the PLGA nanofiber microsheets to induce CaP
nucleation. In addition, a layer-by-layer approach was used to improve the diffusion of
calcium and phosphate ions inside the microsheets in order to achieve a high CaP to fiber
ratio.
The cortical bone composed of osteons that have microtubular structures with a
central vascular channel inside for ensuring suitable nutrient/waste transport to the bone
tissue [11]. Laminated multilayers of CaP deposited collagen fibers forms the osteon
microtubes. Therefore, engineered bone grafts that can mimic the microstructure of bone
would be a strong candidate for bone tissue engineering applications. The physical
configuration of the scaffolds, which mediate the cell-cell and cell-scaffold interactions,
exert strong influence on the success of osteogenic processes in vitro [174, 175]. The
success of engineered scaffold mostly depends on how closely the cell-scaffold
relationship mimics that natural tissue in vivo. Both in vitro and in vivo studies have
demonstrated the organic/inorganic composite fibrous scaffolds support attachment,
differentiation, and proliferation of osteoblasts or mesenchymal stem cells (MSCs) and
facilitate bone healing [116]. However, investigations regarding the effect of osteonmimetic tubular scaffolds size (inner diameter) with 3-D morphology on osteogenic
differentiation of MSCs are still limited. To this end, we hypothesized that three
dimensional structure of microtubes with well-defined pores could potentially mimic the
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microstructure of osteons in cortical bone and induce osteogenesis of MSCs. In order to
test this hypothesis, we investigated the osteogenic differentiation potential of MSCs
when seeded into different diameter microtubes engineered from CaP deposited aligned
nanofiber microsheets that have an array of macropores to enhance diffusion of nutrients.
The microtube structure fabricated by wrapping perforated microsheets around the
stainless steel needles upon annealing above glass transation temperature (Tg) of PLGA.
The effect of tubular formation and the inner diameter of CaP deposited microsheets on
osteogenic differentiation of rat MSCs was investigated by cytochemicalanalysis. Our
results indicate that the 3-D microtubes provide a promising microenvironment that
enhances osteogenesis. However, changing the inner diameter of the osteon-mimetic
microtubes

did

not

change

the

cytochemical

analysis

significantly.

4.2 MATERIALS AND METHODS
4.2.1 FABRICATION OF MINERALIZED GLUTAMIC ACID TEMPLATED
PEPTIDE

CONJUGATED

PLGA

NANOFIBERS

MICROSHEETS

AND

MICROTUBES
The CaP nucleated microsheets in Chapter 3 were used for fabricating the osteonmimetic microtubes. Beriefly, the EEGGC peptide was synthesized manually on Rink
Amide NovaGelTM resins as described [100, 125, 126]. Briefly, rink amide NovaGelTM
resin (100g) was incubated in DMF (3 ml) for 30 min to swell completely. Then, the resin
was washed with DMF (23 ml). Fmoc-protected amino acid derivative (6 eq.) and HOBt
(12 eq.) were dissolved in dry DMF (3 ml). Next, DIC (6.6 eq.) as an accelerator was
added to the mixture. Then, the resulting mixture was shaken 5-10 min and added to the
resins. Next, 0.2 ml DMAP (0.05 M) was added to the mixture. The mixture was placed
in an orbit shaker for 4-6 hr at 30C. The reaction was tested using Kaiser reagents. If the
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test result was positive, the above coupling reaction would be repeated until a negative
result was reached. After the reaction, the resins were washed with DMF (53 ml) and
treated with 20% piperidine in DMF for 2  15 min in order to deprotect the F-moc
groups of the amino acids. The subsequent amino acids were coupled using the same
method. After peptide chain elongation, the resins were washed with 5  DMF and 5 
DCM. The EEGGC peptide was cleaved from the resin by treating with 95% TFA/2.5%
TIPS/2.5% water and precipitated in cold ether. After drying, the EEGGC peptide was
conjugated to poly (lactide) acrylate (PLAA, MW=4000 Da) macromer by Michael’s
addition reaction between the acrylate group on the macromer and the cysteine’s
sulfhydryl group on the peptide to produce a PLAA-EEGGC conjugate. A mixture of the
peptide and PLAA macromer (2:1 molar ratio) was dissolved in a 1:1 mixture of
DMF:water, and allowed to react at 30°C overnight in an orbital shaker. The mixture was
dialyzed against DI water and lyophilized to obtain the dry product.
Electrospinning solutions of high molecular weight PLGA (10 wt%) and mixtures
of PLAA conjugated EEGGC peptide (1.5% of PLGA amount) were prepared in
hexafluoro-2-propanol (HFIP). A programmable KDS100 syringe pump (KD Scientific,
Holliston, MA) was used to pump the polymer solution, which was inside a 1 ml syringe
(Norm-Ject, Henke Sass Wolf GmbH, Tuttingen, Germany) to the end of a 21 GTW
needle (PrecisionGlide, 0.81 mm O.D., Becton-Dickinson, Franklin, NJ) at a specified
flow rate of 1.0 ml/h. The 20 kV positively charged Pt electrode of a high voltage supply
(ES40P-5W/DAM, Gamma High Voltage Research) was connected to the needle. A
high-speed rotational wheel collector (custom built in the Machine Shop at University of
South Carolina) was used to prepare glutamic acid template aligned nanofiber
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microsheets (GLU-NF). A grounded aluminum wheel (20 cm diameter and 5 mm
thickness) powered by a high speed DC motor (2M0578, up to 5000 rpm, Dayton
Electric, Niles, IL) was used to collect nanofibers and placed at 7.5 cm underneath the
needle. The force generated by the high electric field between the needle and the rotating
wheel overcame the surface tension of the polymer solution and stretched the accelerating
jet as fibers toward the collector while the solvent evaporated during the process. The
polymer jet, after deposition on the collector, was further stretched by the tangential force
produced by the rotation of the wheel and formed aligned fibers on the edge of the wheel.
Mineralization of nanofiber microsheets was occurred by depositing the apatite
crystals on nanofiber microsheets via using Lie et al.’s modified 10-fold-concentrated
simulated body fluid (m10SBF(1). Briefly, the stock solution of 10SBF was prepared by
dissolving NaCl, KCl, CaCl2• H2O, MgCl2• 6H2O and NaH2PO4 in distilled deionized
(DDI) water (10SBF stock solution pH=4.2). Next, in order to reach physiological pH of
7.4, 60 mM of NaHCO3 was dissolved in the 10SBF stock solution prior to
mineralization process. The impurities and formed large CaP crystals in the pH range of
5.9 to 7.4 were removed by filtering the solution through a 0.22 μm pore size filter
system. Nanofiber microsheets were then immersed in m10SBF filled plastic beaker and
kept at room temperature for 6h and 24h. The m10SBF was replaced with fresh m10SBF
every 6 h over apatite growth cycle. After removal from m10SBF, the nanofiber
microsheets were washed with DDI water three times and then dried at room temperature.
In the layer-by-layer approach, the first GLU-NF microsheet, approximately 5 µm thick,
was electrospun on a 12 mm circular glass coverslip (VWR, Bristol, CT). Next, the
microsheet was incubated in m10SBF for the prescribed time, washed with DI, and dried.
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After drying, the second GLU-NF layer was electrospun directly on the first layer. The
bilayer sheet was incubated in m10SBF for a prescribed time, washed with DI, and dried.
This layer-by-layer process was repeated five times to produce a 26±2 μm thick
mineralized multilayer GLU-NF circular sheet (12 mm diameter). The multilayer
approach improved diffusion of calcium and phosphate ions inside the fiber sheet when
incubated in m10SBF solution. Scanning electron microscope (SEM) was used to image
the nanofibers microsheets with different CaP content. After coating the samples with
gold (Poloron sputter coater, Quorum Technologies, New Haven, UK) at 20 mA for 45
sec, the microsheets was attached to a SEM stub with double-sided conductive tape and
imaged with a Field Emission Scanning Electron Microscope (FESEM, Carl Zeiss
Microscopy, Hillsboro, OR) at an accelerating voltage of 8kV. SEM images were
analyzed with Image J software (National Institutes of Health, Bethesda, MD) to measure
the size of the nanofibers and CaP crystals.
CaP nucleated elctrospun microsheets (5 cm length*1 cm witdh) wrapped around
the 21 GTW needle (PrecisionGlide, 0.81 mm O.D., Becton-Dickinson, Franklin, NJ) and
placed in pre-heated 80 Co oven for 10 min to anneal the structure of the microsheets and
keep it’s microtubalar structure by shape memory effect. Prior to wrapping the
microsheets around the needle, uniform micropores were created by 29 GTV needle
(PrecisionGlide, 0.34 mm O.D., Becton-Dickinson, Franklin, NJ) on the microsheets to
induce diffusion of nutrients and oxygen during the cell culture period. Different
diameter microtubes were fabricated by using different size of needles by following the
explained procedure above. The porosity and density of the CaP nucleated NF
microsheets before and after heat treatment were calculated using Eq. (1) and Eq. (2).
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The thickness and size of the microsheets were measured using a micrometer caliper
(VWR, Atlanta, GA). The tensile modulus of the samples before and after heat treatment
was measured with a Rheometrics Dynamic Mechanical Analyzer (RSA III DMA,
Piscataway, NJ) with a strain rate of 0.033/s. Samples were cut to dimensions of 20x5
mm and mounted in the standard vertical clamps of the DMA. The maximum allowed
strain was set at 160% and measurements were made at ambient conditions. The
thickness and width of the samples were measured with a micro-caliper (Mitutoyo,
Aurora, IL). The modulus was calculated as the slope of the linear region of the stressstrain curve.

(1)

(2)
MSCs were isolated from the bone marrow of young adult male Wistar rats (6-8
weeks) [93, 100, 125, 176]. Cell isolations were performed under a protocol approved by
the Institutional Animal Care and Use Committee of the University of South Carolina.
Wistar rats were sacrificed, and femurs and tibias were aseptically removed. The marrow
was flushed out with 20 ml of cell isolation medium which consisted of DMEM
supplemented with 10% FBS, 100 µg/µL streptomycin, 100 units/mL penicillin, 20
µg/mL fungizone, and 50 µg/mL GS. The cell suspension was centrifuged at 200g for 5
min and the cell pellets were re-suspended in 12 ml of primary medium (DMEM
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supplemented with 10% FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, 50
µg/mL GS, and 250 ng/mL fungizone), aliquoted into T-75 flasks and maintained in a
humidified 5% CO2 incubator at 37 °C. Cultures were washed with PBS and replaced
with fresh media at 3 and 7 days to remove unattached cells. Cells were rinsed with PBS,
enzymatically lifted with 25 µL/cm2 0.05% trypsin/ 0.53 mM EDTA and centrifuged at
200g for 5 min. The third passage cells were used for cell culture experiments. Cell
attachment to the nanofiber mesh was done with undifferentiated MSCs cultured in the
primary medium.
MSCs were characterized by immunostaining of specific surface markers. Isolated
MSCs were fixed with 4% paraformdehyde for 30 min, permeabilized with 0.1% Triton
X-100 and 100 mM glycine in PBS (pH 7.4) for 1 h and blocked with blocking solution
including 1.5% BSA and 0.5 mM glycine in PBS for 2 h. The primary antibodies used for
MSCs characterization are CD73, CD90, VE-cadherin, and CD-31 (Pecam-1). The
primary antibodies diluted in blocking solution for 1:100 and incubated with cells for 12–
16 h at 4 °C. Secondary antibodies (Alexa fluor® 488, 593 obtained from Molecular
Probes, Invitrogen) were used at 1:100 dilutions in blocking buffer for 2 h at room
temperature in the dark. Nuclei were stained with DAPI (4, 6-diamidino-2-phenylindole,
100 ng/ml). Images of the cells visualized using a fluorescence microscope (Zeiss LSM
510 Meta CSLM).
The 0.8 mm and 0.35 mm diameter microtubes were sterilized by ultraviolet
radiation for 12 h with a mercury UV lamp (Black-Ray, 365 nm, 100 W; UVP, Upland,
CA), followed by immersing in 70% ethanol for 30 min and washing three times with
sterile PBS. The microtubes and microsheets were conditioned by immersion in primary
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culture media for 1 h prior to cell seeding. Each sample was seeded with 5 µL of the
MSCs cell suspension (5 x 106 cells/mL) in primary media at 1 x 105 cells/cm2 seeding
density by using syringe which has 0.25 mm diameter sterile needle. After 24 h
incubation for cell attachment, the media were replaced with osteogenic media (primary
media supplemented with 100 nM dexamethasone, 50 µg/mL ascorbic acid, 10 mM ßglycerophosphate) and cultured in a humidified 5% CO2 incubator for up to 28 days.
MSCs seeded GLU-NF, GLU-NF/CaP30, and GLU-NF/CaP50 microsheets were
incubated with 0.16 µM Alexa Fluor® 594 phalloidin (Invitrogen) and 300 nM DAPI for
30 min at ambient conditions to stain the cell actin filaments and nuclei, respectively. The
cell morphology on each sample was imaged with a Nikon Eclipse Ti-ε inverted
fluorescent microscope.
4.2.2 OSTEOGENIC DIFFERENTIATION OF MSCs SEEDED IN MICROTUBES
AND ON MICROSHEETS
At each time point (7, 14, and 28 days), cell-seeded microtubes were washed with
serum-free DMEM for 8 h to remove serum components, then washed with PBS, lysed
with 10 mM Tris supplemented with 0.2% triton in PBS and used for the measurement of
DNA content, ALPase activity, calcium content, and total collagen content. The doublestranded DNA content of the samples was determined by using a Quant-it PicoGreen
assay (Invitrogen, Carlsbad, CA) according to the manufacturer’s instruction. An aliquot
(100 µl) of the working solution was added to 100 µl of the cell lysate and incubated for
4 min at ambient conditions. The fluorescence was measured with a Synergy HT plate
reader (Bio-Tek; Winooski, VT) at emission and excitation wavelengths of 485 and 528
nm, respectively. ALPase activity was assessed using a QuantiChrom ALPase Assay Kit
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(BioAssay Systems, Hayward, CA) according to the manufacturer’s instruction. A 10 µl
aliquot of the cell lysate was added to 190 µl of the reagent solution containing 10 mM pnitrophenyl phosphate and 5 mM magnesium acetate, and the absorbance was recorded at
time zero and again after 4min. ALPase activity was calculated using the equation [(At=4
– At=0)/ (Acalibrator – AddH2O) x 808] expressed as IU/L. The absorbance was measured on a
Synergy HT plate reader at 405 nm. The calcium content was measured using a
QuantiChrom Calcium Assay Kit (BioAssay Systems) according to the manufacturer’s
instruction. A 0.2 ml aliquot of 2 M HCl was added to 0.2 ml of the cell lysate to dissolve
the calcium content of the mineralized matrix. Next, a 5 µl aliquot of the supernatant was
added to 200 µl of the working solution. After incubation for 3 min, the absorbance was
measured with a plate reader at 612 nm. Measured intensities were correlated to
equivalent amounts of Ca2+ using a calibration curve constructed with calcium chloride
solutions of known concentration ranging from 0 to 200 µg/mL. For CaP deposited
samples, the measured intensities after incubating with cell lysing solution at day 0 were
used as the baseline, and subtracted from the measured intensities at days 7–28. Alkaline
phosphatase activity and calcium content were normalized to the DNA amount at specific
time point. Collagen production was analyzed by SIRCOL collagen assay kit protocol
(Biocolor, Newtownabbey, UK) in the supernatants after 7, 14 and 28 days of cell
culture in microtubes. The collagen containing supernatant from the culture was mixed
with 1 mL of Sircol dye for 30 min and centrifuged at 10,000 rpm for 5 min to precipitate
the collagen–dye complex. After decanting the suspension, pellets were dissolved in 1
mL Sircol alkali reagent and vortexed. Subsequently, 100 μl of the acquired solution was
read at 555 nm. The amount of collagen was calculated based on a standard curve of
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Sircol Rat Collagen Reference Standard (Biocolor). Cell lysate solution was used as a
negative control.
4.3 RESULTS AND DISCUSSION
4.3.1 PROPERTIES OF OSTEON-MIMETIC MICROTUBES
The ideal three dimensional bone tissue engineering scaffolds must be porous
enough to support nutrients and oxygen transfer, mimic the micro and nanoscale features
of the cortical bone, and composed of biodegradable and biocompatible material [177].
Although numerous different types of three-dimensional scaffolds have been fabricated,
none of them completely mimics the micro- and nano structure of the natural bone tissue.
For this purpose, in this study we used CaP nucleated PLGA based perforated nanofiber
microsheets to fabricate microtubular scaffolds by using heat treatment. In order to
enhance porosity of the tubular scaffolds, array of 180 µm diameter perforated holes were
made on microtubular scaffolds.
In this study, NF microsheets were fabricated by electrospinning of 10 wt%
PLGA concentration, 1.0 µL/h injection rate, 20 kV electric potential, needle-to-wheel
distance, wheel diameter, and rotation speed of the wheel 7.5 cm, 20 cm, and 1200 rpm,
respectively [93, 173, 178]. The solution concentration (viscosity) has a major effect on
NF morphology. For example, we have previously shown that the minimum polymer
concentration to produce bead-free fibers, in HFIP was 9 wt.% [93]. Below that critical
concentration, surface tension breaks the accelerating jet of fibers into droplets.
Morphological structure of GLU-NF in this work indicates that formed NF have
diameters similar to collagen fibers (50-500 nm), a major bone extracellular matrix
component [119]. It was reported that nanofibrous scaffolds enhanced osteogenic
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differentiation. For example, Smith et al. compared the osteogenic ability of nanofibrous
matrix to solid films by seeding mouse embryonic stem cells and culturing in osteogenic
media for 26 days. They showed significantly higher osteocalcin and bone sialoprotein
expression on the nanofibrous matrix compared to those on the solid films [179]. In
addition, Hu et al. cultured MC3T3-E1 cells on flat and nanofibrous PLLA films to test
the ability of the matrix to support osteogenesis. They demonstrated that the cells on the
nanofibrous showed higher levels of osteocalcin and bone sialoprotein expression
compared to flat films after 6 days [180].
In our previous study (Chapter 3), the calcium and phosphate crystals content of
GLU-NF microsheets after incubation in mSBF at different time points were measured.
The results shows that 30% (GLU-NF/CaP30), 50% (GLU-NF/CaP50) and 200%
(LBL/CaP200) CaP content based on the CaP to fiber weight ratio were fabricated after
incubation GLU-NF microsshets in mSBF for 6h and 24h, respectively (Chapter 3). The
SEM images of GLU-NF (a), GLU-NF/CaP30 (b), GLU-NF/CaP50 (c), and
LBL/CaP200 microsheets are shown in Figure 4.1, respectively. CaP crystals nucleated
from the fiber surface after 6 h incubation can be seen in Figure 4.1b. As incubation time
increased to 24 h, the amount of CaP crystals increased significantly, as shown in Figures
4.1c, respectively. Figure 4.1d shows CaP nucleated nanofibers by layer-by-layer
application, as it is seen in the image the content of CaP crystals with the average size of
100 nm increased significantly with layer-by-layer method (The procedure for fabrication
of LBL-CaP200 microsheets is explained in Chapter 3.2). We have shown that, LBL
approach resulted with a dramatic increase in CaP content from 50±6 to 200±5%,
indicating that CaP nucleation and growth on GLU-NF fibers was controlled by diffusion
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of calcium/phosphate ions from the medium to inside the microsheets. The image of
GLU-NF microsheets before and after heat treatment is shown in Figure 4.2a and Figure
4.2b, respectively. The average size of the microsheets before and after heat treatment
was 8.7x10.7x0.05 mm, 9.7x13.2x0.04 mm, respectively. The heat treatment resulted
with the significantly shrinkage of the nanofiber microsheets.

Figure 4.1 SEM images of the microsheets after incubation in m10SBF medium. Images
(a) and (b) are low magnification images of PLGA and PLGA/PLA-GLU microsheets
after incubation in m10SBF for 24 h, respectively. Images (b) and (c) are for PLGA/PLAGLU microsheets after 6, and 24 h incubation in m10SBF, respectively. Image (d) is for
PLGA/PLA-GLU microsheets deposited with CaP crystals in a layer-by-layer (LBL)
approach. Scale bars in (a-d) represent 200 nm, respectively.

Mineralization in osteons occurs under the function of glutamic-acid rich residues
of bone sialoprotein and osteonectin [181, 182].

Therefore, peptides including

polyglutamic acid sequences have been widely investigated to determine the interaction
with nHA crystals. For example, Itoh et al. coated HA with the synthetic peptide
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(E7PRGDT), and seeded osteoblastic cells onto the surface. They demonstrated that the
amount of E7PRGDT peptide containing polyglutamic acid sequence bound to HA was
higher than passively adsorbed RGD at all coating concentrations due to high affinity of
polyglutamic acid peptide to nHA crystals [183]. In addition, Sarvestani et al. treated the
surface of nHA particles with glutamic acid peptide (Ac-Glu6). It was indicated that the
average density of elastically active chains in the PLEOF network increased significantly
when nHA in the network were treated with the osteonectin-derived Ac-Glu6 [173].
Similar to others, in our previous study, conjugation of glutamic acid template peptide on
NF significantly increased the CaP nucleation (Chapter 3). Thus, in this study we used
the glutamic acid conjugated NF to nucleate the CaP crystals. 50 % CaP to fiber mass
ratio (GLU-NF/CaP50) was used to fabricate the osteon-mimetic microtubes. The microtubuler structure of the biofabricated scaffolds ideally mimics the osteons structures in
cortical bone [184].
The effect of the heat treatment on GLU-NF, GLU-NF/CaP30, GLU-NF/CaP50,
and LBL/CaP200 microsheets porosity and density are shown in Figure 4.2c and 4.2d,
respectively. The results indicated that the porosity of the CaP nucleated microsheets
after heating decreased significantly for all the test groups. In addition, the appeareant
density of different CaP containing GLU-NF microsheets was increased significantly for
each test group after heat treatment. The tensile modulus of the microsheets before and
after heat treatment is shown in Figure 4.2e. The heat treatment significantly increased
the tensile modulus of the CaP nucleated GLU-NF microsheets. For example, the tensile
modulus of GLU-NF/CaP50 microsheets increased from 539±3 MPa to 770±65 MPa. It
was demonstrated that there was a significant increase in tensile modulus on GLU-
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NF/CaP50 microsheets after heat treatment. These results indicated that the stiffness of
GLU-NF/CaP50 microsheets was increased by heat-shrinking the microsheets. Similar
with our results, it has been reported that with the increasing the apatite content in
nanofibrous microsheets, the tensile modulus of the microsheets increases significantly
[185]. In addition, incorporation of nHA crystals in polycaprolactone fibers increases the
tensile modulus of fabricated electrospun NF [149]. Overall, nAP deposited GLU-cNF
have the potential to provide higher structural support to progenitor cells compared to NF
with no nAP content. It has been observed that increasing mineral content on NF
significantly enhanced MSCs adhesion and differentiation [186].

Figure 4.2 Effect of heat treatment on the aligned nanofiber microsheet shrinkage before
heating (a) and after heating (b). The effect of heat shrinking on porosity(c), density(d)
and tensile modulus(e). Experimental groups include GLU-NF, GLU-NF/CaP30, GLUNF/CaP50, and GLU-NF/LBL200. One star indicates statistically significant difference
(s.d.; p<0.05) between before annealing and after annealing for the same experimental
group. Error bars correspond to means ± 1 SD for n = 3.
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Figure 4.3 SEM image of CaP deposited nanofiber microsheet with array of circular
macropores(a), SEM image of microtube fabricated by wrapping a perforated microsheet
around a needle followed by heat treatment at 80 Co for 10 min (b), and the image of
perforated microtube bundles of twenty microtubes with the average microtube diameter
of 450 µm (c), SEM images of different inner diameter microtubes 250 µm (d), 450 µm
(e), and 800 µm (f).
The limitation of nanofibers fabrication with electrospinning is that it produces a
relatively two dimensional fibrous scaffolds. In addition, the pore sizes are relatively
smaller which does not allow cells to penetrate into the scaffold [177]. To overcome
these problems, perforated nanofibrous microsheets were used to fabricate three
dimensional microtubes with different diameters. This biofabrication technique could be
a potential way to develop highly porous 3D nanofibrous scaffolds. The SEM images of
micropores structures on the microsheets and microtubes after heat treatment are shown
in Figure 4.3a and Figure 4.3b. The average size of the micropores was 180 µm. The
microtubes were fabricated in different inner diameters by wrapping the perforated
microsheets around different size needles. In figure 4.3, SEM images of different inner
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diameter microtubes 250µm (d), 450 µm (e), and 800(f) are shown. The fabricated
microtubes bundled together by annealing at 80 Co for 10 min. Figure 4.3c shows the
bundle of microtubes average individual tube size of 450 µm. This biofabrication
technique of osteon-mimetic tubular scaffolds would enable to develop larger scale bone
grafts with the nanofbirous structure and microscale osteon size.
4.3.2

OSTEOGENIC

DIFFERENTIATION

OF

MSCs

IN

MINERALIZED

MICROTUBES AND ON MICROSHEETS
The immunohistochemistry images of MSCs for Cd73, CD90, VE-cadherin, and
CD-31 (PECAM-1) are shown in Figure 4.4a1-4.4a4. The results indicated that MSCs
had strong CD73 and CD90 expression, whereas there was no VE-cadherin and CD-31
expression. Similar with our results, Gustafsson et al. and Valarmathi et al. demonstrated
that isolated rat MSCs exhibited high expression of mesenchymal markers of CD73, and
CD90 and negative expression for CD-31 and VE-cadherin[187, 188].
In order to observe the morphology of individual cells, MSCs were seeded on the
microsheets at low density of 1500 cells/cm2 and incubated in osteogenic medium.
Fluorescent images (a-c) of cell nuclei (blue) and cytoskeletal actin filaments (red) in
Figure 4.4b1-4.4b4 show morphology of the MSCs seeded on GLU-NF (a), GLUNF/CaP30 (b), and GLU-NF/CaP50 (c) and LBL/CaP200 microsheets after two days of
incubation. The images indicate that the seeded cells completely aligned with fiber
direction irrespective with CaP nucleation. Inset images in Figure 4.4b1-4.4b4 show the
SEM images of corresponding GLU-NF (a), GLU-NF/CaP30 (b), GLU-NF/CaP50 (c),
and LBL/CaP200 microsheets.
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Figure 4.4 The immunohistochemistry images of MSCs stained with CD73(a1), CD90
(a2), VE-cadherin(a3) and CD-31(a4). Morphology of MSCs seeded on GLU-NF(b1),
GLU-NF/CaP30(b2), GLU-NF/CaP50(b3), and GLU-NF/LBL200(b4) microsheets after
seven days of incubation in osteogenic medium (scale bar is 100 µm). In the images, cell
nuclei and cytoskeletal actin are stained with DAPI (blue) and phalloidin (red),
respectively. The arrow in the images shows direction of the aligned nanofibers. The
inset in each image shows the corrosponding SEM images of the GLU conjugated
nanofiber microsheets before (GLU-NF, a) and after incubation in m10SBF medium for
6h (GLU-NF/CaP30, b) and 24h (GLU-NF/CaP50, c) (scale bar is 2 µm).
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MSCs differentiation into an osteogenic lineage occurs in a two-stage maturation
process, where ALPase increases and peaks in the early stage of osteogenic
differentiation and mineralization, and then decreases while calcium content starts to
increase [151]. For both experimental groups, the DNA content after 7 days started to
decrease gradually. It has been demonstrated that differentiation of MSCs osteogenic
media significantly reduces the proliferation of MSCs [93, 189]. MSCs were seeded in
0.35 mm (MT, 0.35mm), and 0.8 mm (MT, 0.8 mm) diameter microtubes and cultured in
osteogenic media for 28 days. DNA content, ALPase activity, calcium content, and total
collagen content of the MSCs were analyzed as a function of incubation time. Figure 4.5a
shows the DNA content of the MSCs 0.35 mm, and 0.8 mm diameter microtubes as a
function of incubation time. The time points for osteogenic differentiation of MSCs were
7, 14, and 28 days. Since the cell seeding density kept constant for all experimental
groups (1x105 cells/cm2), the DNA content in 0.35 mm microtubes was significantly
lower than 0.8 mm microtubes and microsheets. In addition, it was indicated that the CaP
deposited microsheets and formed microtubes did not have a toxic effect on the seeded
cells.
ALPase activity of the MSCs in 0.8 mm, and 0.35 mm diameter microtubes as a
function of incubation time is shown in Figure 4.5b. In the experimental groups, ALPase
activity peaked after 14 days, then it started to decrease gradually for different size
microtubes cultures. The results indicated that there was no significant difference
between 0.8 mm and 0.35 mm microtubes on day 14. For example, the the peak value of
ALPase activity of MSCs in 0.35 mm, and 0.8 mm microtubes 4370±654, and 5275±685
IU/mgDNA at day 14, respectively. ALPase activity of all other groups, incubated in
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osteogenic medium, peaked after 14 days and returned to baseline level at day 28,
consistent with previous reports [151]. These results indicated that the inner diameter of
the microtubes did not affect on the ALPase activity of MSCs. It was demonstrated that
ALPase activity of MC3T3-E1 preosteoblast cells on apatite coated poly (ε-caprolactone)
(PCL) fibers was higher than uncoated PCL fibers [123]. In addition, it was reported that
the presence of nHA on poly-caprolactone fibers enhanced the ALP activity of MC3T3E1 preosteoblast cells [190]. This result is consistent with previous results that showed
the calcium content of MSCs on aligned and random PLAA NF significantly increased
with time [93]. High ALPase expression is a marker of maturation phase of MSCs, while
high expression of OC and OP represents mineralization phase of osteogenic
differentiation of MSCs [178]. In addition, it was demonstrated that ALPase expression
decreases during the mineralization phase of MSCs [191].
Calcium content of the MSCs in microtubes (0.35mm and 0.8 mm) as a function
of incubation time is shown in Figure 4.5c. The results indicated that there was no
significant difference on the Ca content of 0.35 mm and 0.8 mm microtube groups on
calcium content. For example, the calcium content in 0.35 mm microtubes were 453±59,
and 0.8 mm microtubes were 635±41 mg Ca/mg DNA, respectively. All calcium
measurements were subtracted from the amount at day 0 to remove the calcium due to
CaP deposition prior to cell seeding. For all groups, extent of mineralization of the MSCs
increased gradually from day 7 to 28 in osteogenic medium. This result is consistent with
previous results that showed the calcium content of MSCs on aligned and random PLAA
NF significantly increased with time [93].
The total collagen production in microtubes (0.35 and 0.8 mm) is showed in
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Figure 4.5d. The secretion of newly formed collagen is important to enhance the stability
of the mineralized microtubes and microsheets during the culture. For example, the total
collagen production of MSCs in microtubes (0.35 and 0.8 mm) was 472±75, 821±95, and
983±127 μg Collagen/μg DNA after 28 days, respectively. There was no significant
difference on collagen secretion between 0.35 mm and 0.8 mm microtubes. Moreover,
the total collagen content gradually increased in both microtubes and microsheets culture
with the increase of incubation time.

Figure 4.5 DNA content (a), alkaline phosphatase activity (b), calcium content (c), and
total collagen amount (d) of MSCs seeded inside GLU-NF/CaP50 microtubes cultured in
osteogenic media. Experimental groups include GLU-NF/CaP50 0.35 mm microtubes
(green), and 0.8 mm diameter microtubes (red). Time points include 7, 14, 28 days. Error
bars correspond to means ± 1 SD for n = 3.

The heat treatment of the microsheets improved the mechanical properties of the
CaP nucleated GLU-NF microsheets. Our results indicate that the tensile modulus of
GLU-NF increases by increasing the CaP content and heat treatment of the microsheets.
This was consistent with the previously reported results showing that increasing the
apatite amount on NF significantly increases the tensile modulus [185]. Moreover, it was
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reported that incorporation of nHA crystals in polycaprolactone fibers increased the
tensile modulus of fabricated electrospun NF [149]. Overall, the engineered microtubes
from CaP nucleated GLU-NF have the potential to provide structural support to
progenitor cells in bone tissue regeneration.
4.4 CONCLUSION
In this study, our objective was to investigate the effect of inner diameter of
microtubes on osteogenic differentiation of rat MSCs. Extensive in vitro characterization
indicated that the microtubular scaffolds are not only able to support cell attachment and
proliferation, but also to provide an environment which improves the osteogenic
differentiation of MSCs. This was confirmed by the increasing alkaline phosphatase
activity, calcium phosphate deposition, and collagen content. In addition, the fabricated
microtubes could be fused and larger scale tubular scaffolds for bone grafts application
could be fabricated. It was also demonstrated that changing the inner diameter of the
microtubes from 0.8 to 0.35 mm did not change the cytochemical results significantly.
Present findings demonstrate that the 3D structure of microrubular scaffolds provide a
promising microenvironment that enhances osteogenesis.
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CHAPTER 5
VASCULOGENIC DIFFERENTIATION OF MARROW STROMAL CELLS (MSCs)
and ENDOTHELIAL PROGENITOR CELLS (EPCs) IN OSTEON-MIMETIC
MINERALIZED NANOFIBROUS MICROTUBES

5.1 INTRODUCTION
The cortical bone composed of osteons that have microtube like structures with a
central vascular channel inside for ensuring suitable nutrient/waste transport to the bone
tissue [11]. Laminated multilayers of CaP deposited collagen fibers forms the osteon
microtubes. The development of three-dimensional (3-D) bone tissue in-vitro has been
limited by the need to create a vascular network within the tissue to supply required
oxygen and nutrients to maintain tissue viability and function [192]. Vascularization
inside the scaffold enhances diffusion and provides optimal nutrient/waste transport for
engineered scaffolds [193]. The combination of endothelial progenirator cells (EPCs)
with marrow stromal cells and seeded into engineered bone grafts has been offered as a
promising and efficient approach to enhance vascularization and promote successful bone
formation at the graft site [194-196]. For instance, cocultures of EPCs with MSCs in
poly(lactic-co-glycolic acid) [PLGA] have shown enhanced microvascular network
formation [197]. Therefore, engineered bone grafts that can mimic the microstructure of
bone and have pre-vascularized structures that induce nutrients transport would be a
strong candidate for bone tissue engineering applications.
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The physical configuration of the scaffolds, which mediate the cell-cell and cellscaffold interactions, exert strong influence on the success of osteogenic and
vasculogenic processes in vitro [174, 175]. The success of engineered scaffold mostly
depends on how closely the cell-scaffold relationship mimics that natural tissue in vivo.
The effect of the size of fabricated microtubes on EPCs/MSCs vasculogenic
differentiation has not been studied yet. To this end, we hypothesized that 3D structure of
microtubes with well-defined pores could potentially mimic the microstructure of osteons
in cortical bone and induce vasculogenesis of MSCs and EPCs. In order to test this
hypothesis, we investigated the vasculogenic differentiation potential of MSCs/EPCs
when co-cultured and seeded into microtubes engineered from CaP deposited aligned
nanofiber microsheets that have an array of macropores to enhance diffusion of nutrients.
The microtube structure fabricated by wrapping CaP deposited nanofiber layers around
the stainless steel needles upon application of heat energy to fuse by raising the
temperature above PLGA glass transation temperature. Our results indicate that the 3-D
microtubes provide a promising microenvironment that enhances vascularization of
MSCs-EPCs co-culture.
5.2 MATERIALS AND METHODS
5.2.1 MATERIALS
N,N-Dimethylformamide

(DMF),

methylene

chloride

(DCM),

N,N

diisopropylethylamine (DIEA), N,N′-di- isopropylcarbodiimide , triisopropylsilane
(TIPS), N,N-dimethylaminopyridine (DMAP), hydroxybenzotriazole (HOBt) and
trifluoroacetic acid (TFA) were received from Acros Organics (Pittsburgh, PA). Diethyl
ether and hexane were obtained from VWR (Bristol, CT). Piperidine, and triethylamine
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(TEA) were purchased from Aldrich (Milwaukee, WI).The protected amino acids and
Rink Amide NovaGel resin were purchased from EMD Biosciences (San Diego, CA).
Dulbecco’s phosphate-buffered saline (PBS) and Dulbecco’s Modified Eagle’s Medium
(DMEM; 4.5 g/L glucose with L-glutamine and without sodium pyruvate) were obtained
from Cellgro (Herndon, VA). Ethylenediamine- tetraacetic acid disodium salt (EDTA),
penicillin, and paraformaldehyde were purchased from Sigma (St. Louis, MO). All other
solvents and chemicals were used as received. QuantiChrom Calcium Assay Kit, and
QuantiChrom ALPase assay kits were purchased from Bioassay Systems (Hayward, CA).
Sircol Collagen Assay kit was purchased from Biocolor Life Science assays (Antrim,
United Kingdom). Alexa Fluor® 594 phalloidin, Trypsin, and 4',6-diamidino-2phenylindole (DAPI) were purchased from Invitrogen (Carlsbad, CA). All the antibodies
for immunostaining were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
The PLGA (Durect Corporation, Pelham, AL) sample was a 50/50 copolymer of D, Llactide and glycolide monomers with intrinsic viscosity of 1.1 dL/g and weight average
molecular weight of 105 kDa. 1, 1, 1, 3, 3, 3-hexafluoro-2-propanol (HFIP), was
purchased from VWR (West Chester, PA). Reagent grade chemicals (Fisher Scientific)
were used in the preparation of m10SBF solution: NaCl, KCl, CaCl2• H2O, MgCl2•
6H2O, NaH2PO4, NaHCO3. Matrigel was purchased from BD Biosciences (San Jose,
California). CellTracker™ (Red) and Calcein-AM (Green) were obtained from Invitrogen
(Carlsbad, CA). EBM-2 medium and following growth factors and supplements of the
media such as vascular endothelial growth factor (VEGF), human fibroblast growth
factor-B (hFGF-B) R3-insulin like growth factor (R3-IGF-1), human epidermal growth
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factor (hEGF), ascorbic acid hydrocortisone, gentamycin, and amphotericin B were
purchased from Lonza (Hopkinton, MA).
5.2.2 FABRICATION OF MINERALIZED GLUTAMIC ACID TEMPLATED
PEPTIDE CONJUGATED NANOFIBROUS MICROTUBES
The EEGGC peptide was synthesized manually on Rink Amide NovaGel TM resins
as described [100, 125, 126]. Briefly, rink amide NovaGelTM resin (100g) was incubated
in DMF (3 ml) for 30 min to swell completely. Then, the resin was washed with DMF
(23 ml). Fmoc-protected amino acid derivative (6 eq.) and HOBt (12 eq.) were
dissolved in dry DMF (3 ml). Next, DIC (6.6 eq.) as an accelerator was added to the
mixture. Then, the resulting mixture was shaken 5-10 min and added to the resins. Then,
0.2 ml DMAP (0.05 M) was added to the mixture. The mixture was placed in an orbit
shaker for 4-6 hr at 30C. The reaction was tested using Kaiser reagents. If the test result
was positive, the above coupling reaction would be repeated until a negative result was
reached. After the reaction, the resins were washed with DMF (53 ml) and treated with
20% piperidine in DMF for 2  15 min in order to deprotect the F-moc groups of the
amino acids. The subsequent amino acids were coupled using the same method. After
peptide chain elongation, the resins were washed with 5  DMF and 5  DCM. The
EEGGC peptide was cleaved from the resin by treating with 95% TFA/2.5% TIPS/2.5%
water and precipitated in cold ether. After drying, the EEGGC peptide was conjugated to
poly (lactide) acrylate (PLAA, MW=4000 Da) macromer by Michael’s addition reaction
between the acrylate group on the macromer and the cysteine’s sulfhydryl group on the
peptide to produce a PLAA-EEGGC conjugate. A mixture of the peptide and PLAA
macromer (2:1 molar ratio) was dissolved in a 1:1 mixture of DMF:water, and allowed to
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react at 30°C overnight in an orbital shaker. The mixture was dialyzed against DI water
and lyophilized to obtain the dry product.
Electrospinning solutions of high molecular weight PLGA (10w%) and mixtures
of PLAA conjugated EEGGC peptide (1.5% of PLGA amount) were prepared in HFIP. A
programmable KDS100 syringe pump (KD Scientific, Holliston, MA) was used to pump
the polymer solution, which was inside a 1 ml syringe (Norm-Ject, Henke Sass Wolf
GmbH, Tuttingen, Germany) to the end of a 21 GTW needle (PrecisionGlide, 0.81 mm
O.D., Becton-Dickinson, Franklin, NJ) at a specified flow rate of 1.0 ml/h. The 20 kV
positively charged Pt electrode of a high voltage supply (ES40P-5W/DAM, Gamma High
Voltage Research) was connected to the needle. A high-speed rotational wheel collector
(custom built in the Machine Shop at University of South Carolina) was used to prepare
glutamic acid template aligned nanofiber microsheets (GLU-NF). A grounded aluminum
wheel (20 cm diameter and 5 mm thickness) powered by a high speed DC motor
(2M0578, up to 5000 rpm, Dayton Electric, Niles, IL) was used to collect nanofibers and
placed at 7.5 cm underneath the needle. The force generated by the high electric field
between the needle and the rotating wheel overcame the surface tension of the polymer
solution and stretched the accelerating jet as fibers toward the collector while the solvent
evaporated during the process. The polymer jet, after deposition on the collector, was
further stretched by the tangential force produced by the rotation of the wheel and formed
aligned fibers on the edge of the wheel.
Mineralization of nanofiber microsheets was occurred by depositing the apatite
crystals on nanofiber microsheets via using Lie et al.’s modified 10-fold-concentrated
simulated body fluid (m10SBF(1). Briefly, the stock solution of 10SBF was prepared by
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dissolving NaCl, KCl, CaCl2• H2O, MgCl2• 6H2O and NaH2PO4 in distilled deionized
(DDI) water (10SBF stock solution pH=4.2). Next, in order to reach physiological pH of
7.4, 60 mM of NaHCO3 was dissolved in the 10SBF stock solution prior to
mineralization process. The impurities and formed large CaP crystals in the pH range of
5.9 to 7.4 were removed by filtering the solution through a 0.22 μm pore size filter
system. Nanofiber microsheets were then immersed in m10SBF filled plastic beaker and
kept at room temperature for 6h and 24h. The m10SBF was replaced with fresh m10SBF
every 6 h over apatite growth cycle. After removal from m10SBF, the nanofiber
microsheets were washed with DDI water three times and then dried at room temperature.
CaP nucleated elctrospun microsheets (5 cm length*1 cm witdh) wrapped around
the 21 GTW needle (PrecisionGlide, 0.81 mm O.D., Becton-Dickinson, Franklin, NJ) and
placed in pre-heated 80 Co oven for 10 min in order to let the microsheets shrink and
keep it’s microtubalar structure by shape memory effect. Prior to wrapping the
microsheets around the needle, uniform micropores were created by 29 GTV needle
(PrecisionGlide, 0.34 mm O.D., Becton-Dickinson, Franklin, NJ) on the microsheets to
induce diffusion of nutrients and oxygen during the cell culture period.
5.2.3 MSCs and EPCs ISOLATION, CHARACTERIZATION AND SEEDING
MSCs were isolated from the bone marrow of young adult male Wistar rats (6-8
weeks) [93, 100, 125, 176]. Cell isolations were performed under a protocol approved by
the Institutional Animal Care and Use Committee of the University of South Carolina.
Wistar rats were sacrificed, and femurs and tibias were aseptically removed. The marrow
was flushed out with 20 ml of cell isolation medium which consisted of DMEM
supplemented with 10% FBS, 100 µg/µL streptomycin, 100 units/mL penicillin, 20
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µg/mL fungizone, and 50 µg/mL GS. The cell suspension was centrifuged at 200g for 5
min and the cell pellets were re-suspended in 12 ml of primary medium (DMEM
supplemented with 10% FBS, 100 units/mL penicillin, 100 µg/mL streptomycin, 50
µg/mL GS, and 250 ng/mL fungizone), aliquoted into T-75 flasks and maintained in a
humidified 5% CO2 incubator at 37 °C. Cultures were washed with PBS and replaced
with fresh media at 3 and 7 days to remove unattached cells. Cells were rinsed with PBS,
enzymatically lifted with 25 µL/cm2 0.05% trypsin/ 0.53 mM EDTA and centrifuged at
200g for 5 min. The third passage cells were used for cell culture experiments. Cell
attachment to the nanofiber mesh was done with undifferentiated MSCs cultured in the
primary medium.
EPCs were isolated from the bone marrow of young male Wistar rats (6-8 weeks).
After euthanasia, the femurs and tibias were aseptically excised from the hind limbs and
washed in DMEM medium. To expose the marrow cavity, the distal end of tibia and
proximal end of femur were cut off. Small holes were bored in the other end of bone with
18 gauge needle. Next, the bone marrow was flushed out by gently flushing the inside of
the bones with Medium199 supplemented with 20% FBS, 1% Pen/Strep, 1% L-Glu, 1%
sodium pyruvate and 22.5 µg/ml heparin. Cell clumps were broken up by repeatedly
pipetting. The cell suspension was centrifuged at 200g for 5 min. Next, the cell pellet was
re-suspended in the medium199 and plated on rat-derived fibronectin-coated 6-well plate
(1µg/ml). After 24h, the non-adherent cell population supernatant was recovered and
transferred to a new fibronectin-coated plate. After another 24h, this procedure was
repeated to remove rapidly adherent hematopoietic cells or mature EC being possibly
present in the aspirate. Only the non-adherent cell population harvested after 48 h was
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evaluated further in all experiments.
MSCs and EPCs were characterized by immunostaining of specific surface
markers. Isolated MSCs and EPCs were fixed with 4% paraformdehyde for 30 min,
permeabilized with 0.1% Triton X-100 and 100 mM glycine in PBS (pH 7.4) for 1 h and
blocked with blocking solution including 1.5% BSA and 0.5 mM glycine in PBS for 2 h.
The primary antibodies used for MSCs characterization are CD73, CD90, VE-cadherin,
and vWF. The primary antibodies used for EPCs characterization are VE-cadherin, vWF,
PECAM-1, Flk-1, CD73, and CD90. The primary antibodies diluted in blocking solution
for 1:100 and incubated with cells for 12–16 h at 4 °C. Secondary antibodies (Alexa
fluor® 488, 593 obtained from Molecular Probes, Invitrogen) were used at 1:100 dilutions
in blocking buffer for 2 h at room temperature in the dark. Nuclei were stained with
DAPI (4, 6-diamidino-2-phenylindole, 100 ng/ml). Images of the cells were visualized by
using a fluorescence microscope (Zeiss LSM 510 Meta CSLM). MSCs characterization
results were presented in Figure 4.4.
The microtubes were sterilized by ultraviolet radiation for 12 h with a mercury
UV lamp (Black-Ray, 365 nm, 100 W; UVP, Upland, CA), followed by immersing in
70% ethanol for 30 min and washing three times with sterile PBS. The microtubes were
conditioned by immersion in primary culture media for 1 h prior to cell seeding. In order
to form vasculogenesis, EPCs/MSCs were mixed (1:1) in Matigel (derived from a mouse
sarcoma line)- PBS (1:1 mixture) and 5 µl of cell-matrigel suspension were injected
inside the microtubes and cultured in EBM-2 medium containing vascular endothelial
growth factor (VEGF), human fibroblast growth factor-B (hFGF-B), insulin like growth
factor-1 (IGF-1), human epidermal growth factor (hEGF), ascorbic acid hydrocortisone,
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gentamycin, amphotericin B and cultured in a humidified 5% CO2 incubator for up to 12
days. Prior to experiment, EPCs were stained with cell tracer and MSCs were stained
with Calcein-AM. After 12 days of culturing, construct images of the cells were
visualized using a confocal microscope (Zeiss LSM 510 Meta CSLM).
5.2.4 VASCULOGENIC DIFFERENTIATION OF MSCs/EPCs IN MICROTUBES
The DNA and total collagen content in EPC/MSC seeded microtubes were
measured after 3, 6, and 12 days of culture. At each time point, cell-seeded microtubes
were washed with serum-free DMEM for 8 h to remove serum components, then washed
with PBS, lysed with 10 mM Tris supplemented with 0.2% triton in PBS and used for the
measurement of DNA content and total collagen content. The double-stranded DNA
content of the samples was determined by using a Quant-it PicoGreen assay (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instruction. An aliquot (100 µl) of the
working solution was added to 100 µl of the cell lysate and incubated for 4 min at
ambient conditions. The fluorescence was measured with a Synergy HT plate reader
(Bio-Tek; Winooski, VT) at emission and excitation wavelengths of 485 and 528 nm,
respectively. Collagen production was analyzed by SIRCOL collagen assay kit protocol
(Biocolor, Newtownabbey, UK) in the supernatants after 7, 14 and 28 days of cell
culture in microtubes. The collagen containing supernatant from the culture was mixed
with 1 mL of Sircol dye for 30 min and centrifuged at 10,000 rpm for 5 min to precipitate
the collagen–dye complex. After decanting the suspension, pellets were dissolved in 1
mL Sircol alkali reagent and vortexed. Subsequently, 100 μl of the acquired solution was
read at 555 nm. The amount of collagen was calculated based on a standard curve of
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Sircol Rat Collagen Reference Standard (Biocolor). Cell lysate solution was used as a
negative control.
5.2.5 mRNA ANALYSIS OF MSCs/EPCs IN MICROTUBES
At each time point for vasculogenic differentiation samples, total cellular RNA
was isolated using TRIzol (Invitrogen, Carlsbad, CA) plus RNeasy Mini-Kit (Qiagen,
Valencia, CA) according to the manufacturer’s instructions. The qualitative and
quantitative analysis of the RNA samples was performed with NanoDrop 2000 (Thermo
Scientific, Waltham, MA). A 1 µg quantity of the extracted total RNA was subjected to
cDNA conversion using the Reverse Transcription System (Promega, Madison, WI).
Primers for real-time PCR (RT-qPCR) analysis were designed and selected using the
Primer3 web-based software as described elsewhere [125]. RT-qPCR was performed to
analyze the differential expression of platelet/ endothelial cell adhesion molecule 1
(PECAM-1), von Willebrand homology (vWF), vascular endothelial-cadherin (VEcadherin), and endothelial-specific receptor tyrosine kinase (Tie-2) genes with SYBR
green RealMasterMix (Eppendorf, Hamburg, Germany) using a Bio-Rad iCycler machine
(Bio-Rad, Hercules, CA) and iCycler optical interface version 2.3 software. The forward
and reverse primers were synthesized by Integrated DNA technologies (Coralville, IA)
and shown in Table 1. Quantification of gene expression was based on the crossing-point
threshold value (CT; number of cycles required for the RT-qPCR fluorescent signal to
cross the threshold) for each sample. This was evaluated by the Relative Expression
Software Tool [198] as the average of three replicate measurements. The expression of
glyceraldehyde-3- phosphate dehydrogenase (Gapdh) house-keeping gene was used as
the reference. The relative gene expression level was compared to that at time zero using
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2^-ddCT method [199].
Table 2 Forward and reverse sequences of the PCR primers.
Genes

Forward Primer

PECAM-1
VE-cadherin
vWF
Tie-2
GAPDH

Reverse Primer

5`-CGAAATCTAGGCCTCAGCAC-3`
5`-GCACCAGTTTGGCCAATATA-3`
5`-GCTCCAGCAAGTTGAAGACC-3`
5`-CCGTGCTGCTGAACAACTTA-3`
5`-CGA CCT GGA AGT CCA ACT AC-3`

5`-CTTTTTGTCCACGGTCACCT-3`
5`-GGGTTTTTGCATAATAAGCAGG-3`
5` -GCAAGTCACTGTGTGGCACT–3`
5`-AATAGCCGTCCACGATTGTC-3`
5`-ATC TGC TGC ATC TGC TTG-3`

5.2.6 STATISTICAL ANALYSIS
The results are presented as averages and standard errors. Significant differences
between two groups were evaluated using a two-tailed Student’s t-test. A value of p <
0.05 was considered statistically significant.
5.3 RESULTS AND DISCUSSION
The interconnected network of the cortical bone is composed of a set of
microtubular osteons. In this study, the osteon structure was mimicked by fabricating the
CaP nucleated NF based microtubes. The fabricated microtubes were evaluated with
respect to the effect of scaffold morphology on vasculogenesis of MSCs/EPCs. The
osteogenic and vasculogenic differentiation of MSCs and EPCs/MSCs on nanofibers
were previously shown [93, 200]. However the effect of the morphology of the scaffold
on vasculogenic differentiation has not yet been studied. Consequently, the objective of
this study was to determine the in vitro vasculogenic potential of EPCs/MSCs in different
diameter microtubes. The microtubuler structure of the biofabricated scaffolds ideally
mimics the osteons structures of bone tissue [184].
The immunohistochemistry images of EPCs for specific positive and negative
markers are shown in Figure 5.2. The results indicated that EPCs showed positive
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expression of VE-cadherin, vWF, PECAM-1, and Flk-1.

However, there was no

expression of CD73 and CD90. These results are consistent with the previously reported
results.

Figure 5.1 The immunohistochemistry images of EPCs stained with CD31 (a), VEcadherin (b), Flk-1 (c), vWF (d), CD73 (e) and CD90 (f). Scale bar is 100 µm.
The effect of MSCs and EPCs co-culture on vascular structure formation was
investigated. EPCs, MSCs, and EPCs/MSCs one to one ratio co-culture were
encapsulated in Matrigel and cultured in vasculogenic media for 7 days. Figure 5.3a,
5.3b, and 5.3c shows the MSCs, EPCs, and MSCs/EPCs (1:1 co-culture), respectively.
The results demonstrated that only MSCs/EPCs co-cultered formed vascular like
structures when cultured in vasculogenic media for 7 days. These results are consistent
with the previously reported results [194-196].
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Figure 5.2 Confocal microscopic imagesof MSCs (a, green), EPCs (b, red), MSCs/EPCs
cocultured in 1:1 ratio (c) encapsulated in Matrigel and cultured for 7 days in
vasculogenic media. EPCs and MSCs initially stained with cell tracer and calcein AM.
Blue, green and red represents cell nuclei, MSCs and EPCs, respectively.
EPCs/MSCs (1:1) were seeded in GLU-NF/CaP50 0.35 mm, and 0.8 mm
microtubes by mixing (1:1) Matrigel/PBS and cultured in vasculogenic media for 12
days. DNA content and total collagen content of the EPCs/MSCs as a function of
incubation time are shown in Figure 9a, and b. The time points for vasculogenic
differentiation of EPCs/MSCs were 3, 6, and 12 days. The results indicated due to the
lower surface area of the 0.35 mm microtubes, the DNA content was significantly lower
than 0.8 mm microtubes. The total collagen production in 0.35 and 0.8 mm microtubes
are shown in Figure 9b. The results indicated that the inner diameter of the microtubes
did not affect the collagen secretion of MSCs/EPCs when seeded inside the microtubes
significantly. Therefore, the expression levels of vasculogenic markers were only
measured in 0.8 mm microtubes. For example, the collagen production of EPCs/MSCs in
0.35mm and 0.8 mm microtubeswas 132.1±7 and 130.1±9.7 μg Collagen/μg DNA after
12 days, respectively. In addition, the total collagen content was increased in different
diameter microtubes with the increase of incubation time.
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Figure 5.3 DNA content (a) and total collagen amount (b) of differentiating BMS+EPC
cells seeded inside GLU-NF/CaP50 0.35 and 0.8 mm microtubes by mixing matrigel and
cultured in vasculogenic media. Time points include 3, 6, and 12 days. Error bars
correspond to means ±1 SD for n = 3.

A number of early and late stage markers associated with vasculogenic
differentiation in vivo were used in this study to characterize the rat EPCs/MSCs at
mRNA levels, which included CD31/Pecam1, VE-cadherin (CD144), Tie2, and von
Willibrand factor (vWF). Platelet/endothelial cell adhesion molecule is a transmembrane
protein expressed abundantly early in vascular development may mediate leukocyte
adhesion and migration, angiogenesis, and thrombosis [201]. The other early-stage
differentiation marker VE-cadherin, a member of the cadherin family of adhesion
receptors, is a specific and constitutive marker of endothelial cell that plays an important
role in early vascular assembly. Vascular markers that are expressed at a later stage
include vWF and Tie2 [188, 202]. Tie2 is a receptor kinases that is vital for vascular
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development and remodeling in the embryo and functions on maintenance and repair of
vascular system [202]. In late phases of vasculogenesis, the mature endothelial cells will
synthesize and secrete vWF homolog, a plasma protein that mediates platelet adhesion to
damaged blood vessels and stabilizes blood coagulation factor VIII [203]. In order to
investigate the expression pattern of key vasculogenic gene markers of EPCs/MSCs in
microtubes, the expressions of Pecam1, Ve-cadherin, Tie-2 and vWF were analysed at
mRNA level by real-time PCR. RT-qPCR results showed that vasculogenic
differentiation of EPCs/MSCs in vasculogenic culture conditions for 12 days resulted in
an increased expression of vasculogenic gene markers. The peak expression of vWF, Vecadherin and Tie-2 occurred around 12 days (over 350, 90 and 110 fold), indicating that
the differentiating EPCs/MSCs gained the biosynthetic activity of differentiated and
matured endothelial cells. The upregulation of Tie-2 after 3 days might indicate the
development of the vasculogenic structure. Similar to our results, Valarmathi et. al.
demonstrated that vasculogenic differentiation of MSCs in vasculogenic culture
conditions when seeded and cultured in collagen microtubes for 28 days resulted in
increased expression of Pecam1, Kdr, Tie-2 and vWF. They indicated that the peak
expression of vWF around day 21 (over 400 fold) showing that the differentiating cells
became matured endothelial cells and the upregulation of Tie-2 related to development of
the microvessels [188]. Enhanced Pecam-1, VE-cadherin and Tie-2 expression levels in
microtubes culture indicates that tubular formation of the scaffold supported vasculogenic
formation of EPCs/MSCs in matrigel. These results were consistent with the collagen
content results, where EPCs/MSCs in microtubes had increased amount of collagen
content as a function of incubation time.
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Figure 5.4 mRNA expression levels (as fold difference) of platelet endothelial cell
adhesion molecule (a, pecam-1 ) (a), VE-cadherin (b), Tie-2 (c), and Von Willibrand
factor (d, Vwf) of the MSCs/EPCs (1:1), cells seeded inside 0.8 mm microtubes by
mixing matrigel and cultured in vasculogenic media.. Time points include 3, 6, and 12
days. Error bars correspond to means ±1 SD for n = 3.

5.4 CONCLUSION
In this study, our objective was to investigate the vasculagenic differentiation
potential of MSCs/EPCs co-culture in different diameter microtubes fabricated via a
novel biofabrication technique. Extensive in vitro characterization indicated that the
microtubular scaffolds are not only able to support cell attachment and proliferation, but
also to provide an environment which enables vasculogenic differentiation of
MSCs/EPCs. This was confirmed by the enhanced collagen content and expression of
principal vasculogenic genes. Present findings demonstrate that the 3D structure of
microrubular

scaffolds

provide

a

promising

microenvironment

that

enables

vascularization. Overall, the comp;ete results in Chapter 4 and Chapter 5 demonstrates
that the microtubular scaffolds can support osteogenesis and vasculogenesis of MSCs and
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MSCs/EPCs co-culture. Therefore, these scaffolds can be a good candidate for bone
tissue engineering applications.
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CHAPTER 6
CONCLUDING REMARKS
The aim of this work is to fabricate osteon-mimetic nanocomposite scaffolds to be
used as a suitable synthetic matrix in bone tissue engineering applications. The main goal
of bone tissue engineering is to develop bone mimetic scaffolds seeded with
mesenchymal stem cells to regenerate bone defects. Bone tissue engineering scaffolds
required to have specific features such as easy to implant, appropriate physical and
mechanical properties, biodegradable, osteoconductive, biocompatible and cost effective.
Due to the reason that tissue engineered scaffolds will be used to treat the complex bone
defects, these scaffolds should possess similar structural and functional properties of bone
tissue. The cortical bone tissue composed of osteons that have microtube like structures
with a central vascular channel inside for ensuring suitable nutrient/waste transport to the
bone tissue. Laminated multilayers of apatite deposited collagen fibers forms the osteon
microtubes. The apatite nanocrystals provide osteoconductivity and stiffness while the
collagen fibers provide elasticity and a template for mineralization and maturation of
osteoprogenitor cells. Unique factors that contribute to bone toughness are the aligned
network of collagen fibers, apatite nanocrystals, and proteins in the bone extracellular
matrix (ECM) that link the apatite crystals to the collagen fibers. In this work, calciumphosphate nucleated polymeric nanofibers were used to mimic the morphology of the
bone tissue and the effect of calcium phosphate (CaP) deposition on aligned nanofibers
surface-modified with EEGGC glutamic acid peptide on osteogenic differentiation of rat
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marrow stromal cells was investigated. In order to increase CaP to fiber ratio, a layer-bylayer approach was used to improve the diffusion of calcium and phosphate ions inside
the microsheets. CaP to fiber ratio of the microsheets increased from 50% for a single
fiber layer to 200% for the LBL microsheet with the same overall thickness when
incubated in a modified SBF medium. Results demonstrate that surface modification of
nanofibers with GLU peptide dramatically increased nucleation and growth of CaP
nanocrystals on the fiber surface, leading to significantly higher differentiation of MSCs
and mineralized matrix formation. Developed calcium-phosphate nucleated nanofiber
microsheets with an array of macropores to enhance diffusion of nutrients were used to
fabricate osteon-mimetic microtubular scaffolds. The microtubes fabricated by wrapping
CaP deposited nanofiber layers around the stainless steel needles upon annealing above
glass transation temperature (Tg).

The osteogenic and vasculogenic differentiation

potential of MSCs and MSCs/EPCs when seeded into microtubes were invetigated. Our
results indicate that the 3-D microtubes provide a promising microenvironment that
enhances osteogenesis and vascularization. Overall, apatite nucleated electrospun
nanofibers and the microtubes fabricated out of these nanofiber microsheets shows
promising results for clinical usage of these materials as an engineered scaffold. To
continue this work, it is necessary to characterize the compressive mechanical properties
of the fabricated microtubular bundles in order to determine the effective implantation
sites. Furthermore, bone regeneration by using microubular scaffolds should be evaluated
in vivo by animal model including femoral defect, cranial defect or subcutaneous
implantation. To do that, the microtubular scaffolds should be cultured in a perfusion
bioreactor after seeding with MSCs and implanted in a critical size bone defect. X-rays
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and histomorphometric analysis can be used to further characterization of the forming
bone tissue and quantitatively determine the osteoconductivity of the scaffolds. The
potential of osteon-mimetic scaffolds for bone regeneration showed in this work will be
beneficial for clinical development.
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